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Preface 
Abstract 
Alzheimer's disease (AD) is an age-related, neural degenerative disorder, 
associated with a progress decline in intellectual functioning. Unexplained weight 
loss is a frequent clinical feature in AD patients, and hence higher the morbidity 
and mortality. Therefore, identify the nutritional problems in AD patients can 
lessen the health impact. 
The objectives of this project are to assess the nutritional status of AD 
patients, identify associated factors and evaluate potential risk factors on 
predicting weight change over six months. 
45 AD patients were recruited from psychogeriatric clinic and divided into 
the Early stage Alzheimer's disease group (EAD) (n=20) and the Late stage 
Alzheimer's disease group (LAD) (n=25). 36 healthy elderly were also recruited 
from social centres as Control (CTL). 
To assess their nutritional status, at the baseline, anthropometric 
measurements and Mini Nutritional Assessment (MNA) were performed. Four 
categories of factors which might be associated with nutritional status in AD 
patients were measured. Biological factors include energy expenditure, dietary 
intake and olfactory function. Biochemical factors focus on Tumor Necrosis 
Factor (TNF) - a , an indicator of wasting process; Leptin, a regulator of appetite. 
Psychosocial factors refer to neuropsychiatric disturbances valuated by the 
Neuropsychiatric Inventory (NPI). And lastly, the severity of AD was assessed by 
Mini Mental State Examination and Functional Assessment Staging. All subjects 
• also received weight measurement after six months. 
A higher prevalence of malnutrition defined by the MNA or Body Mass 
Index (BMI) was observed in AD patients, especially in the late cases. At the 
i 
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baseline assessments, there were no significant difference between the AD and the 
CTL subjects in the biological and the biochemical factors, except that the AD 
patients performed poorly in olfactory function. Moreover, the plasma leptin 
levels did not correlate with body fat mass in the LAD groups, which implied that 
the regulation of leptin might be impaired in the AD patients at the late stage. 
However, the significance of leptin on dietary intake or nutritional status was not 
apparent. NPI did not correlate with nutritional status. Weight change over six 
months was independently predicted by total daily energy expenditure per lean 
mass and the hallucination subscore of NPI (explained variance: 0.35). 
Average weight change over six months did not correlate with severity of AD, 
however, wider changes in weight in both directions were observed in the LAD 
group. This implied that the progress of AD itself is not a direct cause of poor 
nutritional status observed in its late stages. The lack of regulation of appetite 
control in AD, however, put them at risk of weight loss when there is increased 
energy expenditure related to daily physical activities and psychotic behaviors. It 
is therefore recommended that caregivers should monitor the weight of AD 
patients, and to adjust dietary intake according to changes in activity levels. In 
addition, AD patients with psychotic symptoms may adversely affect their 
nutritional status and the caring capacity of their caregivers indirectly. They 














簡短營養評估（Mini Nutritional Assessment)�四類可能與阿氏痴呆症病者的 
營養狀況有關因素亦同時檢定。生理因素包括熱量消耗，膳食攝取和嗅覺功 
能；生化因素集中在組織壞死因子（Tissue Necrosis Factor)-人體消瘦過程 
的指標和Leptin—控制胃口的蛋白質；心理社會因素則指神經性精神紊亂’ 
由神經性精神調查表（Neuropsychiatric Inventory)；而阿氏痴呆症的病情發展 
是由簡短智力測驗（Mini Mental State Examination)及功能分級化評估 
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1.1 Alzheimer's disease 一 a growing health problem in 
Hong Kong 
Alzheimer's disease (AD) is an age-related neurodegenerative disorder 
characterized by a progressive decline in one's intellectual functioning. 
According to the 1998 to 99 annual report from the Department of Health, 
the population of Hong Kong was 6.7 million. Because of an increased life 
expectancy, Hong Kong's population has been aging steadily. In 1998，those aged 
65 or above accounted for 10.5 % of the population, and it has been estimated to 
increase to 11.2% by the year 2005. In addition, the average life expectancy has 
been steadily rising in the past three decades. In 1998，males reached 77.2 years 
while females had reached 82.6 years. 
According to an epidemiological study of dementia in the Chinese elderly of 
Hong Kong in 1995, the overall prevalence of dementia was 6.1 士 OJo/o; Alzheimer 
disease accounted for 64.6% and vascular dementia accounted for 29.3% (Chiu et 
aL, 1998). 
This epidemiological data of AD revealed several characteristics: First, the 
prevalence of AD increases with age. Age was a significant factor even when sex 
and educational levels were controlled. The rate of AD was about 2% at 75, 7% at 
80 and 14% at 85. Second, educational levels have a significant effect on the rate 
of AD and it remains significant even after controlling for sex and age. Third, 
females had a higher prevalence rate of AD. However, sex became non-significant 
when educational levels were controlled. 
Since the population of HK is rapidly aging, the prevalence of AD is 
# 
increasing with age. Therefore, Alzheimer's disease is a growing health problem 
in Hong Kong. 
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1.2 Pathology of Alzheimer's disease 
Reduced overall brain volume is common in AD. Senile plaques and 
neurofibrillary tangles are the histopatholgical hallmarks of AD. These abnormal 
structures are the consequences of abnormal protein aggregation. 
Senile plagues 
Senile plaques are complex structures and the major constituent is /S 
-Amyloid ( A ) . The predominant specie of AyS is 40 amino acids long (A冷40) 
and about 5% of A/5 is produced as a 42- to 43- residues-long peptide, termed 
“A � 4 2 / 3 ” . A 冷 42/3 could rapidly aggregate and provide a seed for further A 
aggregation. It is observed that the core of senile plaques is A42/3，while A ^ 
40 constitutes the periphery (Richter & Blass, 1994; Wolozin & Behl，2000). 
Neurofibrillary tangles 
Neurofibrillary tangles are composed by bundles of paired helical filaments 
which are consisted by an abnormally phosphorylated tau protein. The abnormal 
tail deposits into nerve cells and hence destmcts them. It first damages the 
dendrites and begins to form a neurofibrillary tangle in the soma (Weaver et al.’ 
2000; Uboga et al, 2000). 
Genetic aspects 
Genetics play a role in the pathogenesis of AD. Apolipoprotein 8 (Apoe) 
gene and p-amyloid precursor protein (APP) gene is identified in association with 
AD. 
Apo has three related gene forms, 82, e3 and 84. It encodes for 
very-low-density lipoproteins and high-density lipoproteins. The role of Apoe 4 in 
the pathogenesis of AD is unclear and several theories have been postulated. 
3 
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However, considerable evidence suggests mutated Apos4 binds strongly with 冷 
-amyloid protein and senile plague formation is promoted (Leon, 1999; Richter & 
Blass, 1994). A previous study on 65 Chinese patients with late-onset AD, and 82 
age- and sex-matched controls, showed that the Apos 4 allele frequency was 
significantly higher in AD patients (Mak et al., 1996). 
APP gene encodes for /3 -amyloid protein. Mutations in APP resulted in the 
increase of A 4 2 / 3 or total A/3 production. This speeded up the kinetics of 
aggregation and led to early-onset disease (Richter & Blass, 1994). 
Mechanisms of Nerve Cell Death 
The formation of senile plaques and neurofibrillary tangles are believed to be 
a central step in the pathogenesis of AD. These abnormal structures cause nerve 
cell death in several pathways. 
The aggregation of protein in plaques and tangles is accelerated by binding 
metals，such as zinc, copper, and iron, which catalyze the conversion of H2O2 to 
hydroxyl radicals ( • OH). When metals accumulate in these abnormal structures, 
OH production thus increases. Excessive oxidative stress induces necrosis and 
hence nerve cell dies (Wolozin & Behl, 2000). 
The abnormal structures also stimulate the activities of the reduced form of 
nicotinamide adenine dinucleotide (NADH) oxidases and hence induces free 
radical production (Yan et al, 1996). 
In addition, microglia and astrocytes are activated by lesions of the brain. 
Resulting in a production of free radical, thus evokes an immune response termed 
inflammation. Inflammation not only attacks the damaged tissue, but also has 
# 
harmful effects on normal neurons. It was the secondary response to the primary 
pathogen, e.g. A p amyloid deposition, but it might cause more neuron loss than 
4 
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the initial injury (Akiyama et al., 2000; Cooper et al.’ 2000). 
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1.3 Clinical features of Alzheimer's disease 
The brain of AD patients degenerates, resulting in a progressive decline of 
intellectual functions. Poor memory usually develops early in AD patients. Other 
features include behavioral changes, mood disturbances, abnormal thinking, 
perceptual abnormalities and impaired insight. 
Co2nitive function 
Forgetfulness is commonly the initial complaint of AD patients. In the initial 
phase, it might be difficult to distinguish from the effects of normal aging. 
Memory loss of recent events is a more obvious characteristic of AD than remote 
events. They also have difficulties in new learning. Attention and concentration is 
impaired, too. Disorientation of time, place and personal identity is common in 
AD patients, especially when the disease has developed to the middle stage. This 
condition becomes obvious when they are in unfamiliar surroundings. As the 
disease progresses, other cognitive functions like visuo-spatial abilities, language, 
and judgment will be affected as well. Eventually, the patients may utter only 
meaningless noises or even become mute. 
Behavioral and psychiatric symptoms 
Behavior may be disorganized and inappropriate. They also lose their 
• interests and there is a lack of initiative. Many patients are restless by day, and 
some sleep poorly at night. Therefore, social behavior declines. In addition, 
aimless，repetitive behavior is common in some patients. Some may wander about 
during the day and some at night. 
Mood disturhancps 
Depressive, euphoric and labile moods are common. There may be a sudden 
6 
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change to anger or tears when patients are taxed beyond their restricted abilities or 
without apparent cause. As dementia progresses, emotions and responses to events 
become generally blunted. 
Abnormal thinkins process 
Thinking becomes slow and impoverished in content. False ideas, often of a 
persecutory kind, develop easily and may progress to delusion. In the late stage, 
thinking becomes grossly fragmented and incoherent. It can be reflected by 
patients' speech. 
Perceptual disturbances 
Illusions and hallucinations are frequently experienced by AD patients. An 
illusion is a misperception of an external stimulus. For example, they may 
misperceive the outline of a bush as a man at dusk when light is poor. While a 
hallucination is a perception experienced in the absence of an external stimulus to 
the corresponding sense organ. It can occur in all sensory modalities, but auditory 
and visual are more common. For example, AD patients may hear a voice when 
no one is speaking. They may see complex images such as animals and children. 
Insisht 
It means a correct awareness of one's own mental condition. Demented 
• subjects frequently lack the ability to appreciate their problems and disabilities. 
General condition 
There is a decline in general condition as the disease progresses. In early 
stage，AD patients remain independent in the activity of daily living and their 
4 
social life is not affected, though their memory is impaired. They can dress, bathe 
and travel to familiar locations by themselves. 
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When the disease develops to the middle stage, the activity of daily living 
becomes partially dependent. Caregivers have to assist the patients in some basic 
tasks of daily life, e.g. managing finical affairs, choosing proper clothing for 
season, toileting and bathing. 
In the final stage of AD, patients become dependent in daily living. Urinary 
and fecal incontinence may occur. Deficits in speech abilities increase with the 
progress of AD. Intelligent vocabulary becomes limited to single words, grunts 
and screams. In addition, patients are not able to recognize familiar persons or 
objects and become non-responsive to external stimulus. They also lose 
ambulatory ability, followed by loss of ability to sit and finally become bed-bond. 




1.4 Clinical diagnosis of Alzheimer's disease 
According to the National Institute of Neurological and Communicative 
Disorders and Stroke (NINCDS) and the Alzheimer's Disease and Related 
Disorders Association (ADRDA), the clinical diagnosis of Alzheimer's disease is 
based on typical clinical presentation with the absences of other possible causes of 
dementia by laboratory tests. Clinical criteria were established for the diagnosis of 
Probable, Possible and Definite Alzheimer's disease, and the details are listed in 
Table from the Report of the NINCDS- ADRDA work group (Appendix 1) 
(McKhanne^ aL, 1984). 
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1.5 Background and objectives of study 
Alzheimer's disease type dementia is a growing health problem and is one of 
the leading causes of disability among elderly. This disease is associated with 
cognitive and behavioral disorders. In addition, substantial weight loss, which 
may increase morbidity and mortality, is a frequent clinical feature in AD patients. 
Understanding of the pathogenesis of the AD associated nutritional problem is a 
strategy to decrease the burden of the disease. 
The present study is a cross-sectional study on the nutritional status of 
Alzheimer's disease patients. The assessment was conducted in the period of 
Oct. 1999 to Sep.2000. All subjects also received body weight measurements after 
six months. 
There are three major objectives. The first objective is to assess the 
nutritional status of AD subjects through questionnaire and anthropometric 
measurements. The second objective is to identify possible factors associated with 
weight loss in elderly. The final objective is to evaluate potential factors 
predicting weight change. 
10 
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1.6 Outlines of the Thesis 
Page No. 
Chapter 1 Introduction 1-11 
Chapter 2 Nutritional aspects of Alzheimer's disease 12-29 
Chapter 3 Methodology 30-61 
Chapter 4 Results 62-83 
Chapter 5 Discussion 84-97 
Chapter 6 Conclusion 98-100 
« 
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2.1 Introduction 
Epidemiological studies have shown that weight loss is commonly associated 
with AD, thus increases morbidity and mortality. The etiology of AD associated 
with weight loss appears multifactorial. Many hypothesis have been postulated to 
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2.2 Weight loss in Alzheimer's disease patients 
In the past two decades, many studies on nutritional aspects of AD patients 
have been carried out. According to the National Institute of Neurological and 
Communicative Disorders and Strokes Task Force on Alzheimer's disease, weight 
loss was a clinical feature consistent with the Diagnosis of AD (McKhann et al.， 
1984). Additionally, in a case-control study that reviewed more than seven 
thousands death certificates of AD patients, nutritional deficiency was a 
frequently associated condition (Chandra et al.，1986). 
In a longitudinal study of weight change in community-dwelling adults, 
subjects were followed for 20 years. Their body weight was measured during each 
clinical visit. The results revealed that both men and women who were later 
diagnosed as AD had significant weight loss when compared to the subjects who 
remained cognitively intact (Barrett-Connor et al., 1996). 
A previous study explored the natural history of weight change in subjects 
with AD. 362 AD patients and 317 healthy elderly were recruited and their body 
weights were measured two or more times each year. The average follow-up 
period was more than two years. The results indicated that there was a greater 
fluctuation of weight in AD patients, which may be a consequence of dysfunction 
in body weight regulation. Moreover, clinically significant weight loss occurred 
more frequently in AD patients (White et al., 1996). 
t 
14 
Nutritional aspects of Alzheimer 's disease 
2.3 Weight loss, morbidity and mortality 
The loss of body weight has a negative effect on morbidity and mortality. It 
increases the risk of decubitus ulcers and systemic infection, and hence worsens 
the quality of life of AD patients and their caregivers. 
A previous study examined the nutritional status and dietary intakes in 
institutionalized patients with AD and multi-infract dementia. They discovered 
that 50% of the demented patients were malnourished despite having an adequate i 
i. 
diet. Additionally, malnourished patients had four times as many infections 
periods than normally nourished patients (Sandman et al., 1987). Though ； 
I 
malnutrition is not always detrimental to the host in terms of survival, the disease 
process seems more severe in a malnourished host. 
Immune functions have a close relation with nutrition. Immunological assays 
can be used as indirect measurement of nutritional status. Every form of 
nutritional disorder causes immunological dysfunction and can be classified as an 
acquired immune deficiency syndrome. Most of them are reversible once the 
nutritional disorder has been corrected (Linder, 1991). 
Weight loss is a common feature associated with generalized malnutrition. It 
is important to note that the function of all active host defensive mechanisms 
require an ongoing capacity of body cells to synthesize new proteins. Therefore, 
malnutrition, especially protein malnutrition, impairs defensive mechanism and 
hence weakens the host's resistance. Both humoral and cell-mediated immunity 
are affected by malnutrition. In short, AD patients with weight loss may have 
lower immune function and hence be more vulnerable to infectious disease, thus 
# 
morbidity is likely to be increased. 
Weight loss is also associated with higher mortality in AD patients. A 
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previous study reported that weight loss that was more than or equal to five 
percent in any year before death was a significant predictor of mortality (White et 
al., 1998). In a three-year longitudinal study of more than nine thousands patients 
with AD aged over 65 years old, malnutrition, with a Body Mass Index (BMI) 
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2.4 Factors contribute to weight loss 
Many factors are associated with weight loss. They can simply be identified 
as biological, biochemical and psychosocial factors. In addition, the progress of 
AD may also play a role in it. Figure 2.1 demonstrates their relationship. 
2.4.1 Progress of Alzheimer's disease 
Weight loss in AD patients is suspected to not be related to any causes, but it 
is a manifestation of AD itself and might be associated with a severity of the 
disease. In a recent longitudinal study over a five-year period of 600 AD patients, jl 
body weight was measured annually. The results showed that nearly a two-pound j'. 
! I 
weight loss was associated with each drop of an AD stage. It concluded that the 
risk of weight loss tended to increase with severity and progression of AD (White i 
etal., 1998). 
2.4.2 Biological factors | 
Inadequate dietary intakes 丨 
Many studies examined the nutritional status of AD patients and also 
investigated their dietary intakes. Earlier studies on institutionalized AD patients 
showed that both normally nourished and malnourished patients had adequate 
energy and protein intakes (Sandman et al, 1987). Consistent results were 
observed from another study on AD patients in elderly home (Renvall et al, 
1993). Another study also reported that AD patients in an elderly home had higher 
energy and protein intakes than community dwelling, cognitively normal elderly 
(Spindler et al., 1996). Since AD patients lose their functional ability to take care 
0 
themselves, most of them were admitted to an elderly home, therefore, data on 
community dwelling AD patients is lacking. 
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Will weight loss in community AD patients happen simply because they 
forget to purchase food, cook or eat? It is valuable to investigate dietary intakes 
and its role on nutritional status in community dwelling AD. 
Elevated Enerev Expenditure 
Energy expenditure has three major components, which are: Basal 
Metabolism (BM), Physical Activity (PA) and Diet-induced Thermogenesis (DIT). 
BA is the minimal metabolic activity required for the basic maintenance of body ^ 
I 
life and its function in the most steady state. PA refers to the increased energy || 
utilized during activity. DIT is described as the food intake itself. It is used to i 
I 
digest, absorb, distribute and store the ingested nutrients. It is unclear whether ； ‘‘1 ‘J 
elevated energy expenditure is associated with weight loss in AD patients. ；, 
i 
1 i t 
A previous study on 25 noninstitutionalized AD patients and 73 healthy ； 
j.� 
elderly found that there was no differences in resting metabolic rate, which is the ！ 
‘I: 
total of BMR and DIT. Both AD patients and healthy elderly had similar !： 
• I； 
nutritional status, their BMI，fat mass and fat-free mass were not very different. f 
秦 
Therefore, the role of energy expenditure in AD patients with malnutrition is not 
known (Donaldson et al., 1996). 
Similar findings were observed in another study on 30 community dwelling 
AD patients and 103 healthy elderly. It showed that daily energy expenditure, 
determined by doubly labeled water, was 14% lower in AD patients. It was 
explained by lower resting and physical activity energy expenditure in AD 
patients. However, there were no significant differences after controlling for the 
differences in body composition. Thus, in a subgroup analysis, cachectic AD 
4 . 
patients had lower daily energy expenditure than non-cachectic patients and 
healthy elderly. The daily energy expenditure became the same after adjusting the 
18 
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differences in body composition. It is concluded that daily energy expenditure was 
appropriate for the AD patients' metabolic size. The findings did not support the 
hypothesis of elevated energy expenditure contributed to weight loss in AD 
patients (Poehlman et al.’ 1997). 
Taste and Olfactory Dysfunction 
Chemosensory deficits in the elderly result from normal aging, but also from 
some other disorders, like Alzheimer's disease. It not only reduces the pleasure ！二 
and comfort from food, it also represents risk factors for nutritional and immune ^ 
deficiencies (Schiffman et al., 1990). II 
I 4 
Taste 1 
Taste receptors consist of a barrel-shaped arrangement of specialized ‘::: 
epithelial cells, called "taste buds", located primarily on the surface of the tongue. ij 
. \ 
Long microvilli project from the tips of these cells and extend through a pore in ：> 
the surface of the taste bud to the external environment where they immerge into 
the saliva. j； 
Taste buds in the posterior third of the tongue are innervated by the ninth 
cranial (glossopharyngeal) nerve; those in the anterior two-thirds of the tongue are 
innervated by the seventh cmial (facial) nerve. The and nerves project to the 
rostral portion of the nucleus of the solitary tract. The solitary tract is the first 
processing area in which taste signals can affect ingestive and digestive activity 
by producing gastric secretion, increased pancreatic exocrine secretion and 
increased secretion of insulin (Fox, 1996; Vander et al., 1994). 
‘ Olfactory 
Olfactory receptor cells are bipolar neurons located in the olfactory 
epithelium on the dorsal aspect of the nasal cavity, the septum, and part of the 
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superior turbinates. The turbinates in the nose create an airflow pattern that allows 
volatile to reach the olfactory cells. Signals are then generated and transmitted to 
the temporal lobe with connection to the hippocampal areas for processing (Fox, 
1996; Vandere^ al., 1994). 
How taste and olfaction work together 
Only four tastes, namely sour, salty, sweet and bitter, can be recognized by 
humans. It is not known how we can distinguish so many different taste sensations ； • 
when the receptor cells lack specificity both in term of the kind of chemical to i 
which they respond and the way they connect to the brain. The odor of the j ' 
！ 
substance clearly helps to identify, like the common experience that food lacks 
taste when one has a head cold (Vander et al., 1994). The sense of olfaction 
strongly influences the sense of taste. All the different tastes that we can perceive 
are combinations of those four，together with the sense of smell. In addition, 
sensations of food in the mouth are presumed to be tastes, but which are in fact 
partially in the oral cavity, so the odorous molecules move up the back of the 
throat and the smell is perceived retronasally. 
How taste and olfactory dysfunction affect dietary intake 
Taste and smell perceptions play an important role in stimulating caloric 
intake and in optimizing nutrient absorption through cephalic phase reflex, which 
triggers salivary, gastric, pancreatic and intestinal secretions for digestion. Deficits 
in taste and olfaction break the reflex and hence delay gastric emptying. They also 
reduce the motivation to eat (Schifftnan & Warwick，1989). Use of flavor 
‘ enhancers may improve food intake and nutritional status in patients with 
impaired taste and smell function (Drewnowski, 1997; Heald & Schiffinan，1997). 
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Chemosensoty deficits in Alzheimer's disease 
Taste deficit is seldom reported in AD patients; however, olfactory 
impairment is common and even serves as a hallmark of AD (Bums, 2000; 
Schiffman, 1993). A previous study on 18 mildly AD patients and 26 healthy 
elderly showed that AD patients perform poorly in odor identification (Rezek, 
1987). Additionally, the degree of one's olfactory deficit is related to the degree of 
dementia. It becomes severe as the disease progress (Murphy, 1993). The causes J 
i 
f: 
of olfactory impairment in AD patients has not been well elucidated; it is believed ； j 
j V 
that the brain degeneration plays a key role as neurofibrillary tangles and senile | 
plaques are always present in the temporal lobe and hippocampus, which is i 
adjacent to the olfactory cortex. Since olfactory, rather than taste losses, are 
responsible for the reduced enjoyment of foods, it is then suspected as a vital 
factor contributes to weight loss in AD patients. : 
2.4.3 Biochemical factors 
The regulator of appetite: Leptin ！ 
Leptin, the product of the obese gene, is composed of 167 amino acids and 
secreted by the adipose tissue. It acts as a hormone to regulate the appetite and 
energy homeostasis from peripheral to central. 
Effects of Leptin 
Leptin was linked to the regulation of body weight because of the 
observations from ob/ob mice. These mice with a mutated obese gene were deficit 
in leptin, resulting in hyperglycemia, hyperinsulinemia, hypothermia and 
increased body fat deposition. Administration of recombinant leptin could lower 
their body weight, percentage of body fat and food intakes. Also, it would 
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increase their metabolic rate. These findings suggested that leptin could normalize 
the metabolism of ob/ob mice via appetite and energy expenditure (Pelleymounter 
et al, 1995). 
Many human studies have shown leptin to be positively correlated with the 
body fat percentage and Body Mass Index (BMI) in different patient groups 
including elderly, patients with chronic heart failure, chronic obstructive airway 
disease, anorexia nervosa, chronic renal failure and gastrointestinal cancer 身 
> 
(Neuhauser-Berthold et al.，2000; Toth et al.，1997; Takabatake et al, 1999; Polito | 
\ 
et al, 2000; Nishikawa et al., 1999; Wallace et al., 1998). 
i 
Although, the findings of leptin and energy expenditure were inconsistent. A j � 
study on free-living elderly showed that leptin was not correlated with their 
Resting Metabolic Rate (Neuhauser-Berthold et al., 2000). While a study on 
anorexia nervosa patients, Basal Metabolic Rate (BMR) was well correlated with 
leptin levels (Polito et al.’ 2000). In addition, leptin levels were related to both ； 
daily and resting energy expenditure in chronic heart failure patients, but not in 
the healthy elderly (Toth et al., 1997). Leptin seems to be associated with energy ’‘ 
expenditure in chronically ill patients but not in the healthy elderly. 
Leptin is thought to be a key modulator of appetite in rodents, however, little 
is known on the effects of humans. Studies on women with moderate energy 
deficiency had shown leptin was associated with self-reported hunger, desire to 
eat and prospective consumption. The findings supported that leptin was a 
physiological regulator of hunger during an energy deficit in humans (Keim et al, 
1998). While another study on obese women showed that leptin was not 
0 
associated with the feeling of hunger or desire to eat (Karhunen et al., 1997). 
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Regulation of energy homeostasis via Leptin 
The regulation of energy homeostasis via leptin is a feedback loop model 
involving the hypothalamus. Leptin is produced by adipose cells, therefore it is 
proportional to body fat and acts as a circulating signal to reflect energy balance. 
When a positive energy balance exists, excessive energy is stored as fat in body. 
The increased fat mass produces more leptin and, hence, its levels are elevated. 
The circulated leptin passes into the Central Nervous System (CNS) and then d 
I 
reaches the hypothalamus. Leptin acts on specific receptors to stimulate satiety via l 
. ‘ .1 downstream neuropeptides. When the peripheral signal, leptin, is enhanced, | ^ 
3 
Neuropeptide Y (NPY) secretion is suppressed. Resulting in decreased food i J 
！ 二 5 
intake and increased energy expenditure, energy homeostasis is then maintained ‘ | 
i f； 
(Inui, 1999; Buchanan et al., 1998; Havel, 1998). ; | 
. N 
NPY, a 36 amino-acid peptide, is synthesized in the neurons of the arcuate ： 
！I 
nucleus of the hypothalamus. NPY serves as an energy homeostasis function to ； | 
maintain body weight under negative energy balance. It can increase food intakes I | 
I .� 
but reduce energy expenditure (Dryden et al, 1994). 
Relation between Leptin and Alzheimer，s disease 
No previous studies on the relationship between leptin and AD patients have 
been reported. It would be valuable to explore this area since unexplained weight 
loss is common in AD patients. Lower plasma leptin levels were expected in AD 
！ 
patients since they were thinner. It is postulated that the regulation of energy 
homeostasis via leptin is dysfunctional in these patients. Since the feedback loop 
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An indicator of wastins process: Tissue Necrosis Factor 
The neurodegeneration in AD patients may be an inflammatory process. 
During the process, the endogenous mediators, cytokines including lymphokines, 
were produced by lymphocytes, monokines and macrophages. Cytokines 
functioned as hormones, stimulating responses in nearby or distant cells and 
tissues. Tissue Necrosis Factor (TNF) was one of the cytokines, mainly secreted 
from monocytes. A previous study on 24 AD patients and 9 age-matched elderly 
demonstrated that there was an elevated circulating TNF levels in AD patients 
(Fillit etal, 1991). 
Tissue Necrosis Factor (TNF) triggered several effects on the host in 
response to inflammation. It stimulated the hypothalamic centre to initiate fever, 
anorexia with secondary hypermetabolism and loss of body nutrients. Moreover, it 
altered the metabolism of macronutrients. These effects may adversely influence 
the nutrition of host (Linder, 1991). 
Protein, amino acid Metabolism 
Amino acid constituted body proteins, especially the contractile proteins of 
skeletal muscle, and they became free after catabolism. The TNF stimulated 
catabolism of skeletal muscle during inflammation. While still in the muscle cell, 
some of the newly released, branched-chain, free amino acids, which are leucine, 
isoleucine, and valine, were deaminated. Their carbon skeletons were oxidized as 
a direct source of cellular energy. The ammonia groups were then reutilized for 
the de novo synthesis of alanine and glutamine within muscle cells through a 
‘ combination with two carbon components derived from amino acids and pyruate. 
The alanine and glutamine then left the muscle and circulated in the plasma. 
Alanine was then uptake by the liver, while glutamine was uptake by kidneys. 
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The uptake of alanine by hepatocyes was accelerated by the TNF. There were two 
main purposes for the influx of amino acids. First, alanine served as the major 
amino acid substrate for gluconeogenesis as the energy source. Second, it was 
used for the synthesis of a new protein, for example, acute phase reactants, 
lipoprotein and enzyme (Linder, 1991; Kotler, 2000). 
Fat Metabolism 
Various cytokines altered lipid metabolism. TNF and interleukin-1 (ILl) 
worked synergistically to inhibit the synthesis of lipoprotein lipase, whose 
function was broken down of lipoprotein. In addition, the cytokines promoted the 
breakdown of fat depot and released fatty acids. Free fatty acids formed a 
complex with albumin in the blood steam. 
Liver cells enhanced the uptake of fatty acids by the stimulation of cytokines. 
Lipogenic activity was increased to assemble fatty acids to triglyceride. 
Triglyceride were either transported to the mitochondria for energy production or 
released in plasma via VLDL. The purpose or potential value ofheptic lipogenesis 
remains unclear (Linder, 1991). 
Carbohydrate Metabolism 
Alteration in carbohydrate metabolism redirected glucose to the liver and 
away from skeletal muscle because hepatic glucokinase was not affected by 
insulin (Kotler, 2000). 
In producing the additional glucose, the liver used all the usual forms of 
substrates. These included glycerol released from triglyceride during lipolysis in 
‘ fat depots and other tissues, lactic acid and pyruvate created by metabolic activity, 
and the gluconeogenesic amino acid from muscle. Because of deamination and 
ureagenesis, the utilization of amino acids as a substrate for glucose production 
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was a costly process for the body in comparison to the other (Linder，1991). 
Relation between TNF and leptin 
The wasting process initiated by TNF, may involve the change of the leptin 
level. Results from previous studies on leptin and TNF in humans were 
inconsistent. Leptin levels were not correlated with TNF or its receptor (R55 and 
R75) in Chronic Obstructive Pulmonary Disease patients (Takabatake et al, 1999). 
However, in patients with a solid tumor, TNF infusion had increased leptin levels. 
It implied TNF might regulate the levels of Leptin (Zumbach et al,, 1997). 
2.4.4 Psychosocial factors 
Neuropsychiatric disturbances 
Neuropsychiatric disturbances, like agitation, irritability, are common in AD 
patients and their effects on nutritional status have not been identified. They are 
believed to influence the nutritional status negatively, however, there are not 
enough evidences to support this hypothesis since few studies work in this area. 
A preliminary study on 32 institutionalized AD patients, using 
Neuropsychiatric Inventory (NPI) to measure neuropsychiatric disturbances, 
revealed that the score of NPI was inversely correlated with BMI and weight 
changes over six months. It concluded that neuropsychiatric disturbances played a 
role in low body weight and weight loss (White et al., 2001). While a local study 
on 51 institutionalized AD patients did not find any relations between the total 
score of NPI and BMI or plasma albumin levels (Pang, 2001). 
The relationship between neuropsychiatric disturbances on one's nutritional 
status remains unclear since these studies were in small scale. 
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Burden of caregivers 
The decline in functional ability and behavioral disturbances of AD patients 
increase the burden of caregivers, which might affect the quality of care. A 
previous study on community dwelling AD patients with a responsible caregiver, 
found that AD patients living with a highly distressed caregiver, evaluated by The 
Zarit scales, might experience greater weight loss. Distressed caregivers might 
explained this observation of a decrease in the quality of care being provided 
(Gillette-Guyonnet et al., 2000). 
«-
27 
Nutritional aspects of Alzheimer disease 
2.5 Background of study 
In the present study, in order to identify nutritional problems in AD patients, 
nutritional status was assessed by anthropometric measurements, body 
composition and questionnaires. 
It is valuable to investigate factors contributing to nutritional status, since the 
findings will be useful in establishing guidelines for caregivers. For biological 
factors, dietary intake was assessed as it is easily modified. Since olfactory 
dysfunctions are common in AD patients, they also need to be assessed to 
understand its effects on dietary intake. Basal metabolic rate and total daily energy 
expenditure was assessed to identify any elevation. For biochemical factors, 
plasma TNF and leptin levels were determined, since therapeutic strategies can be 
applied and prevent AD associated weight loss if there are any abnormalities. For 
psychosocial factors, behavioral disturbances were assessed by the NPI and its 
relation to nutrition was examined. 
< 
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Fig. 2.1 Relationships between progress of Alzheimer's disease, biological, 
biochemical, psychosocial factors, and weight loss. 
Biological factors Biochemical factors 
e.g. energy expenditure e.g. TNF 
energy intakes Leptin 
olfactory function  
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e.g. severity of disease \ 
Functional Assessment Staging \ 
Test \ 
Psychological factors 
e.g. neuropsychiatric disturbances 
burden of caregivers 




Chapter 3 Methodology 
3.1 Subject recruitment 
3.2 Ethical Approval 
3.3 Nutritional assessments 
3.4 Cognitive assessments 
3.5 Factors associated with Nutritional Status 
3.5.1 Biological factors 
3.5.2 Biochemical factors 
3.5.3 Psychosocial factors 
3.6 Statistical Analysis 
30 
Methodology 
3.1 Subject recruitment 
AD patients were recruited from the psychogeriatric out-patients clinic, of 
the Prince of Wales Hospital, HKSAR. They were diagnosed with AD by the 
criteria from the National Institute of Neurological and Communicative Disorders 
and Stroke and the Alzheimer's Disease and Related Disorders Association 
(NINCDS-ADRDA). Healthy elderly were also recruited through social centers as 
Control (CTL). The requirements of all the subjects were that they must be age 60 
or above. All of them were ambulatory, able to feed themselves and live in 
community with a responsible caregiver. These requirements ensured the subjects 
have received good quality of care, with a wide food choice and also excluded the 
factors of weight loss relating to one's disability. 
Reasons for exclusion included: 1) significant or concurrent Parkinson's 
disease, and or other neurodegenerative disorder; 2) major concomitant illness; 3) 
diagnosis of multi-infarct dementia based on neuroimaging; 4) reversible causes 
of dementia; 5) severe cardiovascular disease; 6) hyperthyroidism; 7) epilepsy; 8) 
depression; 9) with terminal disease and subjects who were not expected to 
survive more than six months. 
3.2 Ethical Approval 
This study was approved by the Chinese University of Hong Kong. Written 
informed consent was obtained from the healthy elderly or the caregiver for the 




3.3 Nutritional assessments 
Several methods have been developed to evaluate a person's health from a 
nutritional perspective. These methods can be classified into four categories: a) 
anthropometric measurements, b) clinical examinations, c) biochemical analyses 
and d) nutritional assessment tool. 
(a) Anthropometric measurements 
Anthropometric measurements relate to the physical characteristics of the body, 
such as height, weight and skinfold thickness. It can detect undernutrition and 
ovemutrition by comparing to an individual with population standards specific for 
gender and age. BMI is well-recognized and utilized in many nutritional studies, 
which is easy and requires minimal equipment (Whitney & Hamilton，1996). 
(b) Clinical examination 
Malnutrition and nutrient deficiency can be reflected by physical signs, though 
they are nonspecific and not related to a single nutrient deficit. However, clinical 
examinations are useful for recognizing the severity of malnutrition, and should 
be done by a knowledgeable and skillful nutritionist. Areas to be assessed should 
include hair，eyes, teeth, tongue, skin, fat and muscle, etc. Some advantages of 
these examinations are that it is non-invasive, time-saving, and cost effective. 
However, this method itself is unreliable for the diagnosis of nutritional problems, 
and requires other assessments, say biochemical analyses, to confirm (Under， 
1991; Pressman & Adams，1990). 
(c) Biochemical analyses 
< 
This method helps determine what is happening in the body. It is able to detect 
malnutrition and nutrient deficiency before it progresses to severe and produces 
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clinical signs. It is usually used to identify protein-energy malnutrition by serum 
albumin, to assess vitamin and mineral status. It is accurate, but relatively 
invasive and expensive (Whitney & Hamilton，1996). 
(c) Nutritional assessment tools 
These tools usually include clinical assessment, anthropometric measurements 
and questions to collect information on health, socioeconomic, drug and diet 
history. Subjective Global Assessment and Mini Nutritional Assessment are � 
commonly used. The former must be completed by nutritionists and can determine 
t 
one's nutritional status by their experience. While the later can be administrated 
I 
by a trained assessor and their nutritional status can be determined by the scoring 
system. These tools are noninvasive and easy to administer. (Detsky et al, 1987; 
Vellas et al，2000; Murphy et al，2000) 
Nutritional assessment methods in the present study 
After considering the availability of manpower, financial resources and 
equipment, nutritional assessment in the present study included anthropometric 
measurements included weight, height, tricep and bicep skinfold thickness. In 
addition, body composition was also assessed. Lean mass was estimated by 
bio-impedance while body fat was estimated by a locally divided equation. 
Moreover, Mini Nutritional Assessment (MNA) and BMI, compared to the 
reference, were used to identify malnutrition in subjects. 
3.3.1 Anthropometric measures 
Body weight was measured to the nearest 0.1 kg with subjects in light cloths, 
< 
using an electrical balance (Detect。，EMSD-Medical electronics, US). Height was 
measured with a stadiometer (Seca, Germany) to the nearest one-centimeter while 
subjects were barefoot in a standing position. Body Mass Index was calculated by 
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dividing the subject's body weight on kilograms by the square of the subject's 
height in meters. 
A previous study on 402 subjects, over 60 years of age, has established the 
reference of BMI specific for different age range and gender (Woo et al.’ 1988) 
(Table 3.1). For subjects with BMI lower than the percentiles are classified as 
having malnutrition. 
3.3.2 Triceps and Biceps skinfolds 
\ 
Subjects bended their non-dominant arms at the elbow at a right angle with 
the palm up. The distance between the acromial surface of the scapula (shoulder 
blade) and the olecranon process of the ulna (tip of the elbow) on the back of the 
arm was marked as the mid point. 
With the subject's arm hanging relaxed at the side, the marked midpoint was 
grasped posteriorly between the thumb and forefinger of the examiner. The fold 
was raised, allowing the underlying muscle to fall back to the bone. Then calipers 
were placed (Holtain Ltd., Crymych,UK) on the fold below the fingers. The fold 
was released and the readings were taken to the nearest 0.1mm. Biceps, directly 
above the center of the cubital fossa at the same level oftricep, was also measured 
in the same procedure. For accuracy, measurement was repeated twice, and the 
average was taken. 
3.3.3 Body Composition 
3.3.3.1 Lean Body Mass 
Lean Body Mass (LBM) was estimated by Bioelectrical Impedance Analysis 
(BIA) and using the equations developed by Segal and his colleagues (Segal et al., 




The equation was validated with densitormetrically-determined lean body 
mass on 1069 male and 498 female, aged 17 to 62 years old and with 3-56% body 
fat at four laboratories. All the data was pooled to derive fatness-specific 
equations for predicting LBM. The resulting R values ranged from 0.907 to 0.952 
with SEEs of 1.97-3.03kg (Segal et al.’ 1988). 
(a) Calibration 
BIA (SFB3 Version 1.0，UniQuest Ltd., Australia) has to be calibrated each 
time before use. It was calibrated by a supplied calibration box. First, the leads 
were connected to the terminals on the calibration box and the BIA was turned on. 
The impedance was measured at different resistance from the lowest 409Z, 1 0 �t o 
2000R. 
(b) Subject preparation 
Prior to testing, subjects were fasted overnight. They were not allowed to 
consume alcohol, coffee or exercise excessively the day before. 
(c) Measurement 
1. Subjects layed on their back with legs slightly apart and hands beside the body 
with palms down. The hands were not allowed to touch any part of the body 
and there was not to be any skin to skin contact in the inner thighs. 
2. All skin contact areas were cleaned with alcohol. 
3. Drive electrodes (3M Health Care，USA) connecting the leads via crocodile 
chips were placed below the phalangeral-metacarpal joint in the middle of the 
‘ dorsal side of the right hand and below the metatarsal on the esuperior side of 
the right foot. 
4. Sense electrodes were placed on the posterior side of the right wrist and the 
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medial and lateral malleoli of the right ankle. 
5. Resistance to the flow of a 50-KHZ injected current was measured on a 
O-IOOOQ scale. 
6. The mean value of three measurements without removing the electrodes was 
used. 
3.3.3.2 Body Fat% 
Body fat % (BF%) was estimated by a locally developed equation (Kwok et 
BF% = 6.137*(sex)+1.120*BMI+17.308*[log (Tricep Skinfold thickness + Bicep 
Skinfold thickness)]-27.149 
Sex: Male= 1’ Female = 2 
Validation 
The predictive equation for fat percentages was derived by stepwise multiple 
linear regression on anthropometric indices and gender. A study on 352 females 
and 261 males, aged 69 to 82 years, measured their body weight, standing height, 
arm span, triceps and biceps skinfold thickness, midarm circumference, and total 
body fat percentage by dual-energy X-ray densitometry as the reference method. 
3.3.4 Mini Nutritional Assessment 
Mini Nutritional Assessment (MNA) (Appendix 3) is a tool to identify 
patients at risk from malnutrition or who are already malnourished. 
MNA is composed of fours parts with 18 simple and quick items to measure. 
‘ The first part is the anthropometric assessment which involves Body Mass Index, 
Mid-arm circumferences, calf circumferences and weight loss during the last three 
months in four questions. The second part, with 6 questions, is the general 
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assessment. It is related to lifestyle, medication, mobility, dementia and 
depression. The third part is dietary assessment. Number of meals, food and fluid 
intake，mode of feeding and appetite loss in the last three months were examined 
in 8 questions. Finally, the forth part is a subjective assessment focusing on 
self-perception of health and nutrition. A score assigned to each question and the 
cumulative score of all questions combined the total MNA scores. 
Validation 
MNA was established on 155 elderly subjects, from the very healthy to the 
severely malnourished. MNA was validated by two principal criteria. The first 
standard consists of a nutritional assessment done independently by two 
physicians. The second standard is a comprehensive nutrition assessment 
including anthropometric measurements, evaluation of dietary intake and 
measurements of nutritional biochemistry markers. By discriminant analysis, the 
results showed that MNA identically classified 92% of the subjects with the 
clinical status determined by the physicians. In addition, it matched the 
comprehensive nutrition assessment in 98% of the subjects (Guigoz et al” 1996). 
After the establishment of MNA, several validation studies have been carried 
out. A study on 120 frail elderly in France, showed that concordant identical 
nutritional status was obtained by the MNA without biochemical indices for 89% 
of the subjects (Guigoz et al” 1996). 
Moreover, the classification potential of the MNA was done by 
cross-classification of the subjects in the 1991 and 1993 Toulouse studies. 
Thresholds were selected by cross tabulations of cutoffs for albumin and MNA 
scoring levels. Therefore, MNA equal to or more than 24 points was set for 
"well-nourished", 17 to 23 was "at risk of malnourishment/borderline” and those 
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equal or below 17 was "malnutrition" 
Another longitudinal study in a different cultural context on 
non-institutionalized elderly, the New Mexico Aging Process Study, also found 
that MNA was able to assess nutritional status in the elderly before severe 
changes in weight or albumin levels occurred (Guigoz et al., 1996). 
Administration 
During the first interview, MNA was administrated on all subjects by a 
trained interviewer face to face, following the guidelines from Nestle Nutrition 




3.4 Cognitive assessments 
The Cantonese versions of Mini Mental State Examination (MMSE) 
(Appendix 4) and Functional Assessment Staging (FAST) (Appendix 5) were used 
to assess severity of dementia. 
3.4.1 Mini Mental State Examination (MMSE) 
MMSE is a tool for screening subjects for the presence of cognitive 
impairment. It is most suitable for detecting the cognitive deficits seen in the 
syndrome of dementia and for measuring the cognitive changes over time 
(Cockrell & Folstein, 1988). 
MMSE is divided into two parts. The first of which requires vocal responses 
only. It tests the orientation of place and time, short and long term memory, 
calculation ability and attention. The maximum score is 21. The second part tests 
ability to name, follow verbal and written commands, make a complete sentence 
and copy a complex polygon. The maximum score is nine. Marks are given to 
each successful task and the maximum total score is 30. 
Validation 
MMSE has been established for over 30 years (Folstein et al.’ 1975). 
Successful validity and reliability were obtained. Its score correlated with 
standard tests of cognition, like the Wechesler Adult Intelligence scale (Folstein et 
al., 1975). 
The Cantonese version of MMSE had been validated widely on local 
cognitive normal elderly and demented patients. Several items of the original 
< 
MMSE were modified for local use. 
The cutoff point of classification of the Cantonese version of MMSE was 
based on 298 Chinese elderly, cognitive functions from normal to demented, 
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taking educational levels into account (Chiu et al., 1998). 
A dm in istration 
MMSE was administrated on all subjects face to face by a trained interviewer 
and it took about ten minutes. 
3.4.2 Functional Assessment Staging (FAST) 
FAST is a 16-item scale to mirror the characteristic progression of functional 
loss in AD patients. It is the detailed version of the 7-point Brief Cognitive Rating 
Scale (Reisberg et al., 1983a; Reisberg et al, 1983b) with the corresponding 
Global Deterioration Scale (Reisberg et al., 1982). Its stages are enumerated as 1， 
2，3，4，5，6(a), 6(b), 6(c), 6(d)，6(e)，7(a)，7(b), 7(c), 7(d)，7(e) and 7(f) (Appendix 
5). 
Validation 
FAST had been validated in a study on 50 elderly with normal aging or 
Alzheimer's disease. Successful correlations were obtained between FAST and 10 
independent psychometric test or clinical assessments. 
In another study on 40 AD patients, the Pearson correlation between MMSE 
and FAST was 0.87 (p<0.001) (Reisberg, 1988). 
Administration 
FAST ratings were assessed by a psychiatrist or a trained interviewer based 
on the information provided by primary caregivers and others with knowledge of 
the subjects' functional capacities. The scale points were scored at the level of the 
highest ordinal deficit elicited and followed the guideline from the author 
(Reisberg, 1988). 
Subjects who were ranked as stage 1 or 2 were considered as having normal 
40 
Methodology 
cognitive function. For those who scored 3 or 4 were classified as early 
Alzheimer's disease (EAD) patients while those got score of 5 to 7 were 
considered at late Alzheimer's disease (LAD) patients. 
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3.5 Factors Associated with Nutritional Status 
3.5.1 Biological factors 
3.5.1.1 Evaluation of Dietary Intakes 
Dietary intakes have a close relationship to nutritional status, therefore, it is 
valuable to assess it in a nutritional study. However, weaknesses of data-gathering 
techniques, human behavior, day-to-day variation of individuals' diets, and the 
limitations of nutrient composition tables and databases often complicate dietary 
assessment. Several dietary assessment methods thus have been developed to 
minimize these limitations. 
(a) 24-hour recall method 
The 24-hour recall method is carried out by asking subjects to give detailed 
descriptions of food and beverages that were consumed in the previous 24 hours. 
The advantages are its simplicity and faster time for recording. However, it does 
not cover day-to-day variation of diet (Lee & Nieman, 1993). 
(b) Food record or diary method 
In this method, subjects recorded amounts of all foods and drinks consumed 
and at what time of day for a period ranging from 1 to 7 days. The consumed 
items were quantified by estimating portion sizes or using household 
measurements. The collected information provided detailed dietary intake data, 
and this method is believed to cover day-to-day dietary variation when collected 
up to 5 days. Disadvantages stem from poor compliance in recording the data and 
‘ alteration in eating habits during the study period (Lee & Nieman, 1993). 
(c) Food weighing method 
The Food weighing method requires subjects to weigh and record all 
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individual food items before eating and also the left-overs during the study period. 
It usually lasted for seven days, and could accurately quantify the consumed food 
items. But the main limitations are that it is time consuming and the subject's 
alteration of dietary habits. 
(d) Food frequency method 
The Food frequency method helps to pinpoint food groups, and hence identify 
a specific nutrient that may be excessive or deficient, which is useful in large scale 
epidemiological surveys. The questionnaire includes 100 or fewer individual 
foods or food groups which are known to be major sources of dietary components, 
and subjects have to indicate the frequency and portion sizes they usually 
consumed over a period of time, say a week, month or year. Energy and nutrient 
intakes were estimated by multiplying the portion sizes and frequency. This 
method is easy to carry out and takes relatively a short period of time. But it is 
inaccurate in a quantitative estimation of individual's energy and nutrient intakes. 
(e) Chemical analysis of duplicate diet 
This method is the most accurate measure of dietary intake since it overcomes 
the shortage of food composition database. Subjects were required to give out 
identical portions of all the food items and drinks consumed during the study 
period. The collected items are then chemical analyzed for their nutrient content. 
However, the method is burdensome on subjects and expensive. 
( f ) Photographic records 
In this method, subjects photographed all their food before and after eating. 
< 
Description of food items and preparation methods are also reported. Based on the 
films and the information, energy and nutrient intakes were estimated by 
nutritionists. The advantages were fewer burden and fewer alterations of eating 
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habits，but there are larger capital costs (Simmons & Reuben，2000). 
Dietary assessment method in the present study 
Each dietary assessment has its disadvantages but there are preferred 
methods for a study with defined purpose. The objective of dietary assessment in 
the present study is to estimate the energy and nutrient intakes of subjects. 
A 3-day dietary record was used to evaluate the current dietary intake of the 
subjects. Because detailed dietary information could be obtained, it also covered 
day-to-day dietary variation. The study period was set for three days after 
considering the compliance and ability of the elderly. More than 3 days was too 
burdensome for the subjects and might cause a lack of co-operation from the 
subjects. 
During the first interview, a specially designed record form (Appendix 7) 
was given to the caregivers or the healthy elderly and explained the details in 
recording the dietary intakes. They were asked to record the type, brand name and 
amount of all the foods and beverages the elderly had consumed over the 3 days, 
included 2 weekdays and 1 weekend prior to the second interview. For the AD 
patients，their dietary records were completed by their caregivers while the 
cognitive intact elderly may record by themselves. 
During the second interview, the completed dietary record was further 
discussed. To help quantify the dietary intakes, a photo album which had been 
used in the 1995 Hong Kong Adult Dietary Survey (Leung et al., 1997) consisting 
of commonly consumed foods, bowls, plates, glasses and spoons were shown. In 
addition, cooking methods were reviewed to estimate the amount of oil consumed. 
Dietary practices, such as removing the skin and trimming the fat from meat, were 
asked to obtain a more accurate dietary record. 
44 
Methodology 
To determine the energy, protein, fat, carbohydrate, mineral and vitamin 
intake，the completed dietary record was then analyzed by a food table. (The 
Growth and Nutrition Research team at the department of Paediatrics, The 
Chinese University of Hong Kong) This table is based on food composition tables 
from Britain (McCance et al., 1978)，China (Institute of Health 1980), Taiwan 
(Tung et al, 1961) and US (Church & Church，1975; US Department of Health, 
1972). In addition, chemical analyses of some local Chinese foods from the 
government chemist and product information from the manufacturers are included. 
The accuracy and reliability of the food table in evaluating the nutritional status 
was previously validated with the basal metabolic rate calculation and 24-hour 
sodium/creatinine and potassium/creatinine analysis (Leung et al., 1997). 
3.5,1,2 Enersv Expenditure 
Elevated energy expenditure resulting in energy imbalance is one of the 
causes contributed to poor nutritional status and several methods have been 
developed to estimate total energy expenditure. They can be classified into 
biological methods, motion sensors, and self-reporting. 
(a) Biological methods 
Doubly Labeled Water 
Doubly labeled water is considered as the golden standard in measuring total 
energy expenditure. It measures the disappearance rate of a labeled isotope 
2 18 
(H2 O) from urine samples to estimate carbon dioxide production over a period, 
usually up to seven days. Energy expenditure is then estimated using carbon 
i 
dioxide production and a respiratory quotient based on population norms. A 
disadvantage of this process is the high cost. In addition, it does not discriminate 





This method is based on the linear relationship between heart rate and 
oxygen consumption or energy expenditure during exercise. It has been reported 
to accurately estimate total daily energy expenditure and activity energy 
expenditure in groups, but often results in large individual differences. This 
method is able to distinguish activity patterns, intensity, duration, and frequency 
of activity. However, it does not cover day-to day variation and heart rate is 
influenced by numerous factors other than exercise (Melanson & Freedson, 1996). 
(b) Motion sensors 
This method assumes that movement of the limbs or the whole body reflect 
total energy expenditure. An accelerometer is commonly employed in research. 
Total energy expenditure is based on estimated basal metabolic rate and estimated 
activity energy expenditure by the accelerometer. A prime advantage is it covers 
day-to-day variation. But it is not sensitive to bending, twisting movements, static 
or isometric exercise (Melanson & Freedson，1996). 
(c) Self-reporting 
Questionnaires, interviews, and daily activity diaries are commonly used in 
large-scale epidemiological studies. Some of the advantages are that is 
unobtrusive, nonreactive, covers a variety of activities, easy to administer and 
relatively inexpensive. However, it may alter normal activity patterns. Moreover, 
when converting the activity data to energy expenditure, it is necessary to use 
published tables which may not be suitable for the studied group (Montoye et al” 
1996). Numerous questionnaires have been developed, like the Yale questionnaire 
(Dipietro et al.，1993)，the Baecke questionnaire (Baecke et al.’ 1982)，and the 
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Zutphen questionnaire (Caspersen et al, 1991). 
Methods used in the present study 
In order to examine the role of energy expenditure in the nutritional status of 
AD patients, Basal Metabolic Rate (BMR) and Total Daily Energy Expenditure 
(TDEE) were estimated. BMR was determined by an open-circuit, ventilated flow 
over and indirect system calometry (Deltatrac Metabolic Monitor, Helsinki, 
Finland) because of its accuracy and convenience. While TDEE, included BMR, 
Diet Induced Thermogenesis (DIT) and energy expenditure for physical activity, 
was estimated by a Physical Activity Questionnaire (PAQ) (Liu et al., 2001) 
(Appendix 6). PAQ, though there were a greater individual difference, were 
employed since it was relatively cheaper, did not cause a considerable burden on 
the caregivers，and covered day-to-day variation when compared with other 
methods, like the physical activity dairy or doubly labeled water. 
Basal Metabolic Rate 
(a) Gas Calibration 
Gas calibrations were performed every time before using the calometry. It 
was done by a gas sample with 95% oxygen and 5% carbon dioxide and was used 
for determining the amount of oxygen and carbon dioxide in the sample by using 
paramagnetic oxygen and infra-red carbon dioxide sensors. 
(b) Measurement 
After an overnight fast，subjects laid comfortably in the supine position and 
rested for 10 minutes before measurement. When they were familiar with the 
< 
surroundings and were able stay calm, their heads were placed in a canopy 
connected to the monitor. They were ventilated with a constant flow of about 40 
liters/min of fresh air, and then the oxygen consumption (VO2) and carbon dioxide 
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production (VCO2) was measured. During the measurement, subjects were asked 
to breath normally and stay calm. The expired air was mixed, and the flow rate 
was measured by the flow meters and gas analyzers that quantified the oxygen 
and carbon dioxide. The readings, rate of oxygen consumption and carbon dioxide 
production were taken every minute. The whole measurement took about 20 
minutes. The average of 15 successive readings in a steady state was used to 
calculate BMR by the following equation (Liu et al.’ 2001). 
BMR (kcal) = 5.5 * V02 (ml/min) (STPD) + 1.76 * VC02 (ml/min) (STPD)-
1.99 * Urinary excretion (g/day) 
STPD = standard temperature and pressure, dry gas 
Urinary excretion = 13 g/day 
Total Daily Energy Expenditure 
The Physical Activity Questionnaire (PAQ) is a tool to estimate the Total 
Daily Energy Expenditure (TDEE) by recalling the frequency of activities and the 
time intervals in the previous week. It was mainly based on the modified Yale 
Physical Activity Questionnaire (Dipietro et al, 1993) and the Baecke 
Questionnaire (Baecke et al., 1982). 
The PAQ, with 52 common activities, is divided into five parts: relating to 
occupation, general activity, care-taking activities, exercise and leisure activities. 
Each activity has its corresponding intensity code (kcal/min), which is the energy 
(kcal) spent in a particular activity for one minute. Using a 24-hour period for 
each questionnaire, activities in the hours that have not been accounted for by the 
questionnaire were assumed to be very light activities with an intensity code of 
1.3. The weekly energy expended in the activity can be calculated by multiplying 
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the energy intensity code with the time interval and frequency, correcting for body 
weight. The total energy expended in individual activities was summed and 
divided by seven days to generate TDEE. 
(a) Validation 
The TDEE estimated from the PAQ had been validated with those by BMR 
multiplied by the Physical Activity Level (PAL) obtained from published studies 
using the double-labeled water method and from FAO/WHO/UNU. Successful 
validity was obtained on 94 subjects, consisting of healthy adults, elderly and 
patients with chronic illness. Moreover, reliability was obtained on 71 subjects, 
who were interviewed twice by the same well-trained interviewer within 14 days 
(Liu et al.imy 
(b) Administration 
PAQ was administrated on all subjects by a trained interviewer face to face. 
Cognitive intact elderly were able to give information about their physical activity 
by themselves. However, AD patients, due to their impaired memory, some of the 
information was reported by their primary caregivers. The interview took about 20 
minutes. 
3.5.1,3 Olfactory Function Test 
Olfactory Identification Test (OIT) and Alcohol Sniff Tests (AST) (Appendix 
8) (Tarn, 1999) were performed to assess olfactory function. 
Olfactory Identification Test 
The Olfactory Identification Test (OIT) was originally developed by Murphy 
ef al (1994)，to evaluate the ability to identify odors. OIT in Morgan et al.'s study 
(1995) consisted of six common household odors. They were baby powder, 
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chocolate, cinnamon, coffee, mustard, and peanut butter. The subjects were 
requested to choose among the correct response from a picture, with six target 
odors and fourteen distractions. 
The OIT used on this present study was adapted from Tarn (1999), which had 
been modified to suit the cultural background in Hong Kong. The six common 
household odors were antiseptic germicide, baby powder, chocolate, methodol, 
peanut and Chinese tea. Three were edible and three were inedible. 
Considering the impaired cognitive functions in AD patients, it was possible 
that a poor performance in olfactory identification might be confounded by other 
aging deteriorations like impaired attention, language and the ability to recognize 
objects (Morgan et al.，1995). The Picture Identification Test (PIT) was hence 
carried out prior to the OIT. Subjects were requested to identify all of the items in 
the picture with 6 targets and 14 distractions. For those who could not correctly 
identify 17 items in the picture were excluded. The remaining subjects who 
passed the test were than asked to identify 6 target odors. 
Administration 
The test was carried by a trained interviewer face to face in an 
air-conditioned and odor-free room and took about 10-20 minutes. 
Picture Identification Test 
1. A colored picture with 20 items was placed in front of the subjects. 
2. 5 minutes were given for the subjects to study the picture 
3. In the first trial, every subject was listed the same sequence of items, and were 
‘ asked to point them. 
4. In the second trial, the interviewer pointed at the items that the subject failed 




5. Subjects who were not able to identify more than 16 items in both the first and 
second trials were excluded. 
Olfactory Identification Test 
1. A plastic bottle with antiseptic germicide was placed under both nostrils of the 
subjects with their eyes closed. 
2. Subjects were asked to identify the odor and answered by pointing out the 
specific item on the picture or to respond verbally. 
3. Step 1 and 2 were repeated with different odor stimulus, in sequence of 
Chinese tea, baby powder, peanut and methodol with a one-minute interval. 
4. The number of successful identifications was recorded. 
The Alcohol Sniff Test 
The Alcohol Sniff Test (AST) was used to measure the subject's olfactory 
threshold. It is a rapid, reliable and sensitive test (Davidson & Murphy，1997). 
Admin istration 
The AST was performed by a trained interviewer face to face in an 
air-conditioned and odor free room. A specially designed form with guidelines 
was used to record. (Appendix 8) 
1. A 70% isopropyl alcohol preparation pad was placed beneath the subjects 
nostrils and the subjects were asked to recognize the alcohol odor. 
2. The subjects were asked to close their mouth and eyes and to breath normally. 
3. The alcohol pad was placed at the 30 cm below the nose and moved upwards 
< 
to the nose at each expiration. 
4. The distance between the pad and nose was recorded when subjects indicated 
the detection of the odor. 
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5. The assessment (step3 to 7) was repeated four times with one minute interval. 
6. The mean distance of the five readings was recorded 
3.5.2 Biochemical factors 
Leptin - the resulator of appetite 
Plasma leptin levels were determined by an Enzyme-Linked Immunosorbent 
Assay (ELISA) kit. (DSL-10-23100, Sys Lab Inc., US) It included: 
1. Recombinant Human Leptin Standard; six vials with concentrations of 
approximately 0，0.5, 2.4, 10.0, 25.0 and 50.0 //g/ml, in a protein-based 
buffer with preservatives for setting a standard curve. 
2. Anti-Human Leptin -Coated Microtitration Strip, containing 96 polystyrene 
microtiter wells with anti-human leptin antibodies immobilized to the inside 
wall of each well 
3. Human Leptin Control; two vials containing low and high concentrations in 
protein-based buffer with preservatives for quality control, 
4. Human Leptin Antibody-Enzyme Conjugate Concentrate; 0.3ml of antibody 
conjugated to horseradish peroxidase in a protein-based buffer with 
preservatives. 
5. Assay Buffer; which is a protein-based buffer with non-mercury preservatives. 
6. Tetramethylbenzidine (TMB) Chromogen Solution; 11ml of TMB in Citrate 
buffer with hydrogen peroxide. 
7. Wash Concentrate; buffered saline with a nonionic detergent. 
8. Stopping Solution; 11ml of 0.2M Sulfuric acid. 
Specimen collection and preparation 
1. 5ml plasma by venipuncture was collected from subjects after overnight fast. 
2. The plasma was centrifuged at 3600rpm for 20 minutes at 4°C 
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3. The supernatant was collected and stored at -20°C 
Procedures 
1. All specimens and reagents were thawed, reached room temperature 25°C) 
and mixed thoroughly by gentle inversion. 
2. 25ml of the standards, Control and specimens was pipetted into the 
appropriate wells. 
3. 100ml of the Assay buffer was added to each well by a semi-automatic 
dispenser. 
4. The wells were incubated, and shaken at 700rpm on an orbital microplate 
shaker at room temperature (~25°C) for 2 hours. 
5. The Wash Concentrate was diluted by adding 60ml into 1500ml of deionized 
water. 
6. Each well was aspirated and washed five times with the Wash Solution by an 
automatic microplate washer. 
7. Plate was inverted to blot dry. 
8. Antibody-Enzyme Conjugate Concentrate was diluted by adding 240 " 1 into 
12ml Assay Buffer. 
9. 100//I of the Antibody-Enzyme Conjugate Solution was added to each well 
by a semi-automatic dispenser. 
10. The wells were incubated, and sharken at TOOrpm on an orbital microplate 
shaker at room temperature (-25°C) for 10 minutes. 
11. Plate was inverted to blot dry. 
12. 100//I of the TMB Chromogen Solution was added to each well using a 
semi-automatic dispenser. 
13. The wells were incubated, and sharken at TOOrpm on an orbital microplate 
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shaker at room temperature (-25 °C) for 10 minutes. 
14. 100/zl of the Stopping Solution was added to each well by a semi-automatic 
dispenser. 
15. The absorbance of the solution in the wells was read by a microplate reader set 
to 450nm. 
16. The standard curve was plotted by logging of the absorbance reading for each 
of the Standards along the y-axis versus logging the human leptin 
concentration in ng/ml along the x-axis, using a linear curve fit. 
17. The human leptin concentrations of the Controls were determined from the 
standard curve by matching their absorbance readings with the corresponding 
human leptin concentrations. 
18. Both high and low concentrations of the Controls should fall within 
established confidence limits as an indicator of good quality of the assay. 
19. The human leptin concentrations of each specimen were determined from the 
standard curve. 
S.5.2,2 Tissue Necrosis Factor (TNF) - a plus, an indicator of wastins process 
A human Tissue Necrosis Factor (TNF) - a Immunoassay kit (HSTA50, R & 
D Sys，Inc., US) was used to detect the total amount of TNF- a，including free 
TNF- a and TNF- a bound to soluble receptor in plasma. It included: 
1. TNF- a Microplate; with 96 wells coated with a murine monoclonal antibody 
against TNF- a . 
2. TNF-a Conjugate; 21mL of polyclonal antibody against TNF- a , conjugated 
to alkaline phosphatase, with preservatives. 
3. TNF-a Standard; 3 vials (32pg/vials) of E.Coli-derived recombinant human 
TNF- a in a protein-based buffer with preservatives and lyophilized. 
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4. Assay Diluent; 6ml of a protein-based buffer with preservatives. 
5. Calibrator Diluent; 21ml of animal serum with preservatives. 
6. Wash buffer Concentrate; 100ml of a 5-fold concentrated solution of buffered 
surfactant with preservatives. 
7. Substrate; Lyophilized nicotinamide adenine dinucleotide phosphatase 
(NADPH) with stabilizers. 
8. Substrate Diluent; 7ml of buffered solutions with stabilizers. 
9. Amplifier; lyophilized alcohol dehydrogenase and diaphorase with stabilizers. 
10. Amplifier Diluent; 7ml of buffered solution containing tetrazolium salt 
(INF-violet) with stabilizers. 
11. Stop Solution; 6ml of2M sulfuric acid. 
Specimen Collection and preparation 
1 • 5ml plasma was collected by venipuncture from subjects after overnight fast. 
2. The plasma was centrifuged at 3600rpm for 20 minutes at 4°C. 
3. The supernatant was collected and stored at -20°C. 
Procedures 
1. All specimens and reagents were thawed, reached room temperature ( �2 5 � C ) 
and mixed by gently invert. 
2. TNF-a Standard Preparation 
2.1 TNF-a Standard (32ng) was mixed by gentle agitation, then 1ml 
Calibrator Diluent was added in and mix thoroughly. 
2.2 500 ji 1 32ng/ml standard was pipetted into 500 fi 1 Calibrator Diluent in 
‘ a test tube to produce 16pg/mL 
2.3 Step 2.2 was repeated four times to produce 8，4，2 and 1 ng/ml standard 
by 5-folds dilution. 
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3. 50/zl of Assay Diluent was added to each well 
4. 200 {11 of Standard or specimens was added into each well and incubated for 
15 hours at 4°C. 
5. 100ml Wash Buffer Concentrate was added into 400ml deionized water 
6. Each well was aspirated and washed four times with the Wash Solution by an 
automatic microplate washer. 
7. Plate was inverted to blot dry. 
8. 200;czl of TNF-a Conjugate was added to each well and incubated for 3 
hours at room temperature (-25°C). 
9. Each well was aspirated and washed four times with the Wash Solution by an 
automatic microplate washer. 
10. Plate was inverted to blot dry. 
11. The lyophilized Substrate was added into 6ml Substrate Diluent and mixed 
thoroughly. 
12. 50/zl of Substrate Solution was added into each well and incubated for 60 
minutes at room temperature (-25°C) 
13. The lyophilized Amplifier was added in 6ml Amplirier Diluent and mixed 
thoroughly. 
14. 50/zl of Amplifier Solution was added into each well and incubated for 30 
minutes at room temperature (~25°C). 
15. 50 /z 1 Stop Solution was added to each well. 
16. The absorbances of the solution in the wells were read by a microplate reader 
set to 490nm. 
< 
17. The standard curve was plotted by logging of the absorbance reading for each 
of the Standards along the y-axis versus logging the concentration of the 
Standards in pg/ml along the x-axis, using a linear curve fit. 
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18. TNF- a concentrations of each specimens were determined from the standard 
curve by matching their absorbance readings with the corresponding 
concentrations. 
3.5.3 Psychosocial factors 
Neuropsychiatric Inventory (NPI) 
The Neuropsychiatric Inventory (NPI) (Appendix 9) is a tool to assess and 
measure the neuropsychiatric disturbances in dementia. 
The NPI evaluates twelve behavioral domains, which were chosen after a 
comprehensive literature review on behaviors occurring on dementias and 
preliminary studies of behavioral changes in AD patients (Cummings et al., 1994; 
Cummings, 1997). 
The twelve behavioral domains are (1) Delusion, (2) Hallucinations, (3) 
Agitation / Aggression, (4) Depression, (5)Anxiety, (6)Euphoria, (7) Apathy, (8) 
Disinhibition, (9) Irritability, (10) Aberrant Motor Activity, (ll)sleeping disorder 
and (12) eating disorder. In each behavioral domain, there is a specific screening 
question to provide an overview on that domain, and seven or eight subquestions 
that provide more detailed information about the specific behavioral problem. 
Validation 
The content of the NPI has been validated by rating on representability of the 
screening question and subquestions in each behavioral domain from ten 
well-known experts in geriatric psychiatry, behavioral neurology or 
neuropsychology. 
In addition, study on 40 patients with various types of dementia 
demonstrated a successful correlation between the NPI and the Behavioral 
Symptoms of Alzheimer's Disease in the assessments on delusion, hallucination, 
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affective disturbances, anxiety, aggression and aberrant activity disturbance. 
Acceptable level of validation was also obtained on the NPI depression scale and 
Halmiton Depression Rating Scale. The NPI was also highly reliable in both intra 
and inter observation (Cummings et al., 1994; Cummings, 1997). 
Chinese version of NPI 
The Chinese version of NPI, (Appendix 10) by back-translation, had been 
validated with Behavioral Symptoms of Alzheimer's Disease and the Chinese 
Hamilton Rating Scale of Depression on 62 AD patients and 29 normal elderly. 
Cronbach alpha for the overall reliability was 0.84 and an acceptable false 
negative rates and satisfactory inter-rater reliability had been obtained (Leung et 
fl/.，2001). 
Administration 
The present study used a Chinese version of NPI with twelve behavioral 
domains. The NPI was scored on the basis of information provided by the primary 
caregivers having daily contact with the patients. An interview was conducted by 
a trained interviewer and took approximately 15 to 20 minutes to complete. 
In each behavioral domain, the caregivers were asked by the screening 
question as scripted in the questionnaire whether the patients' behavior had 
changed after the onset of dementia and if the altered behavior had been present 
during a specific period. The behavioral domains would be further explored by the 
subquestions if the caregivers indicated a positive answer to the screening 
questions. Severity (l=mild, 2=moderate, 3=severe) and frequency (1 = 
‘ occasionally, less than one per week, 2 = often, about once a week, 3 ^frequently, 
several times a week but less than every day, 4 = very frequently, once or more 
per day or continuously) were given in each feature. 
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3.6 Statistical Analysis 
Data was analysed with SPSS version 10.0 for Windows (SPSS Inc., Chicago, 
IL，US). 
Three groups of subjects were categorised based on their cognitive function 
through the score of MMSE and FAST. Details were explained in the previous 
section. The Chi Square Test was used to test for association of categorical 
variables among three groups. To test the differences in nonparametric data 
between groups, the Mann-Whitney test was used when there were two groups, 
while the Kruskal-Wallis test was used for other conditions. Univariate Analysis 
of Covariance with age and sex adjustments was used to test the differences of 
continuous variables among the three groups. 
The Multiple linear regression model, with stepwise as the selecting method, 
was used to build with the weight change in six months as the dependent variable. 
Independent variables were age, sex, cognitive function group, BMI on baseline, 
BMR, TDEE, dietary intake, score of MNA, score of NPI, olfactory function, 
plasma leptin and TNF levels. Subjects who failed to attend the six-month follow 





3.1 Reference of Body Mass Index for different age range and gender. 
Aap rVpaiVk Male Female 鄉 ( y e a r s ) IS'""* 
60-64 2L97 24.22 2 L « 2 ^ 5 ~ 
65-69 18.61 21.46 23.23 19.64 22.15 25.56 
70-74 19.20 21.25 24.12 19.44 22.51 25.0+ 
75+ 18.81 21.17 24.02 20.68 22.32 25.15 




Table 3.2 Fatness-specific equations for predicting lean body mass. 
Male Female 
BF%<20% BF% ^  20% BF%<30 BF%^30 
Height: (cm:) 0.00066360 0.00088580 0.00064602 0.00091186 
Resistance (Q) -0.02117 -0.02999 -0.01397 -0.01466 
Weight (kg) 0.62854 0.42688 0.42087 0.29990 
Age (yr) -0.12380 -0.07002 -0.07012 
Intercept 9.33285 14.52435 10.43485 9.37938 
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4.1 Demographic characteristics 
In this study there were originally 81 subjects recruited; 36 cognitively 
normal elderly as Control (CTL)，20 Early Alzheimer's disease (EAD) patients 
and 25 Late Alzheimer's disease (LAD) patients, The mean (士S.D.) ages (year) of 
the subjects were 72.9士6.4 for the CTL group, 75.85士8.0 for the EAD group and 
77.52士5.7 for the LAD respectively. The LAD group was significantly older than 
the CTL group (p<0.05). 
Though there were more female demented patients, up to 70% of the EAD 
group and 84% of the LAD group, no significant differences in sex were observed 
among the three groups (p=0.064). 
The scores of the Cantonese version of MMSE in the CTL, EAD and LAD 
groups were shown in Fig. 4.1. There were significant differences observed 
among the three groups (pO.OOl). 
For the FAST, all the cognitive normal elderly were in either stage 1 (N=22, 
61%) or in stage 2 (N=14, 39%). Some of the EAD patients (N=8, 40%) were in 
stage 3，and some of them (N=ll , 55%) were in stage 4. There was a greater 
variation of FAST in the LAD patients fell in stage 5 to stage 7，with majority in 
stage 5 (N=ll , 55%) and stage 6 (N=9，36%). Significant differences in FAST 




4.2 Nutritional assessments 
The results of anthropometric measurements were shown in Table 4.1. Both 
body weight and BMI was significantly lower in the LAD group than the CTL 
group (p<0.05), but no significant differences were observed between the CTL 
and the EAD groups. 11% (N=4) CTL, 25% (N=5) EAD and 48% (N=12) LAD 
patients had BMI lower than the 25出 percentiles from the reference by the BMI in 
healthy elderly with the same age range and sex, which was considered as a sign 
of malnutrition. Significant differences were observed in the frequency of 
malnutrition by BMI between the three groups (p<0.01). 
The LAD group compared with the CTL group, was significantly lower in 
Body Fat Percentage (BF%), which was estimated by a locally developed 
equation using sex, BMI, and the triceps and biceps skinfolds thickness 
measurements (p<0.01), while no difference was found between the EAD and the 
CTL groups. Lean Body Mass (LBM) (kg), determined by bio-electrical 
impedance, was not significantly different among three groups. Triceps skinfolds 
thickness (TSF) (mm), were significantly lower in both the EAD (p<0.05) and the 
LAD groups (p<0.01) when taking the CTL group as the reference. 
By using a Mini Nutritional Assessment (MNA), a screening tool for 
malnutrition among the elderly, revealed that up to 74% of the LAD group and 
42% of the EAD group was classified as either “at risk of malnourishment" or 
"malnutrition", while 97% of the CTL group was classified as "well-nourished". 
Significant differences were observed among three groups (p<0.001) (Fig.4.2). In 
‘ addition, there were significant differences in the general assessment, dietary 
assessment and self-esteem in the MNA of the three-groups (p<0.001). But there 
were no significant differences observed in the anthropometric assessment of the 
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4.3 Factors associated with Nutritional Status 
4.3.1 Biological factors 
4.3.1.1 Dietary Intake 
26 CTL, 18 EAD and 25 LAD subjects had completed the three-day dietary 
record. The LAD group had a significantly higher caloric intake than the CTL 
group (p<0.05). The significant differences remained the same when their caloric 
intake was divided by their body weight (pO.OOl). No significant differences 
were observed between the EAD and the CTL groups. 
Macronutrients 
The LAD group had a significantly higher protein intake (p<0.05) than the 
CTL group, even when the protein intake divided by body weight (p<0.01). No 
significant differences were found in the EAD and the CTL groups. Fat intake in 
the CTL subjects was significantly higher than the EAD (p<0.05) and the LAD 
subjects (p<0.05). All three groups had no significant differences in their 
carbohydrate intake. In addition, the proportion of the three macronutrients 
(carbohydrate, protein and fat), in terms of energy intake, was not significantly 
different in three groups. 
Micronutrients 
The LAD subjects had significantly lower Vitamin A intake than the CTL 
subjects (p<0.05). But there were no significant differences observed between the 
EAD and the CTL groups. Although, the EAD group had a significantly higher 
‘ Vitamin B1 intake than the CTL group (p<0.01). Additionally, there were no 




The intake of calcium, phosphorus iron fiber and cholesterol had no 
significant differences among the three groups (Table 4.3). 
4.3.1.2 Energy Expenditure 
Basal Metabolic Rate 
The Basal Metabolic Rate (BMR), determined by an indirect calorimeter, 
was not significantly different among the CTL, EAD and LAD groups. The BMR 
among all the subjects was around 1000 kcal per day. There were no significant 
differences of BMR divided by their body weight (kg) or Lean Body Mass (kg) 
among three groups (Table 4.4). 
Total Daily Energy Expenditure 
Total Daily Energy Expenditure (TDEE), estimated by a locally developed 
Physical Activity questionnaire (PAQ), was significantly lower in the EAD group 
(p<0.05) and the LAD group (p<0.001) than the CTL group. The differences 
among the three groups remained the same after the TDEE was divided by their 
body weight or Lean Body Mass (Table 4.4). 
4.3.1.3 Olfactory Function 
Olfactory Identification 
Both the EAD and the LAD subjects performed worse than the CTL subjects 
significantly on the Olfactory Identification Test. The modes of the number of 
successful identifications were 5 for the CTL group, 0 for the EAD group and 0 
for the LAD group (pO.OOl). No correlations were observed between the scores 
‘ of the Olfactory Identification Test and caloric intake. 
Alcohol Sniff Test 
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Both the EAD and the LAD groups had a significantly larger threshold than 
the CTL group in detecting the odor of alcohol (p<0.001). The distances that they 
were able to detect were 17.05土7.00，10.46士7.65 and 7.88士5.73 for the CTL, the 
EAD and the LAD subjects respectively. There was no correlation between the 
threshold and caloric intake. 
4.3.2 Biochemical factors 
4.3.2.1 Leptin 
Plasma leptin levels divided by body fat mass did not significantly differ 
among the CTL, the EAD and the LAD groups (Fig 4.3). The plasma leptin levels 
were well correlated with body fat percentage in the CTL group (r=0.73, p<0.001) 
and the EAD group (r-0.78, p<0.001), but not in the LAD group (r=0.28, p-0.16). 
No correlations were obtained between plasma leptin levels, caloric intakes, basal 
metabolic rate, the self-reports of appetite over the past three months (0=severe 
loss. 0.5=moderate lost, l=no loss) and the score o f M N A in all three groups. 
4JJ.2 Tumor Necrosis Factor (TNF) 
No significant differences were observed among the CTL, the EAD and the 
LAD groups in plasma TNF levels (Fig. 4.4). There were no correlations between 
the plasma leptin levels and plasma TNF levels in all of the three groups. 
Additionally, the plasma TNF levels did not correlate well with the body weight 
and the BMI in all three groups. 
4.3.3 Psychosocial factors 
Neuropsvchiatric Inventory (NPI) 
Both the EAD and the LAD subjects had a significantly higher NPI total 
score than the CTL subjects (p<0.001), but no significant differences were 
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observed between the BAD and the LAD groups. Only a few cognitively normal 
subjects reported that they had experienced hallucination, aggression, depression, 
anxiety, apathy, irritability and sleeping disorder in a mild degree and low 
frequency. Irritability was the most common behavioral problem in the LAD 
subjects, while sleeping disorders were the most common the EAD subjects (Fig. 
4.5). Comparing the behavioral problems in the EAD and the LAD subjects, the 
LAD subjects had a significantly higher score on aberrant motor behavior than EA. 
There were no significant differences in the other eleven domains. 
The NPI total score did not significantly correlate with the subjects' body 
weight and BMI. In addition, none of these domains were correlated with body 
weight and BMI (p>0.05). 
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4.4 Longitudinal observations 
27 (75%) CTL, 19 (95%) EAD and 24 (96%) LAD subjects attended the 
six-month follow up and received weight measurements. Clinical weight loss was 
defined as more than 5% weight loss. Up to 21% (N=5) of the LAD subjects had 
clinical weight loss, while only 5% (N=l) of the EAD and 4% (N=l) of the CTL 
had clinical weight loss. However, it did not reach significant differences. 
There were no significant differences of the weight differences over six 
months within the three groups, while the range of weight difference (kg) was 
closer in the CTL group (range: -6.49 to 5.24) and the EAD group (range: -6.52 to 
5.67). A greater variation was observed in the LAD subjects (range: -12.09 to 
11.51) (Fig. 4.6). 
Table 4.5 shows the correlations of percentage weight change over six 
months. Table 4.6 shows the correlations between percentage weight change over 
six months and neuropsychiatric disturbances in the subjects' NPI. Percentage 
weight change was negatively correlated with delusion (r=0.114, p<0.01), 
hallucination (r=0.132, p<0.01) and aggression (r=0.083, p<0.05). 
Variables with p values lower than 0.25 were included to produce a 
multivariate linear regression model on the weight difference percentage as the 
outcome variable. Using stepwise as the selecting method, only TDEE per LBM 
and the score of hallucination in NPI were possible predictors (r^=0.351) (Fig. 
4.7). Weight change was independent of energy expenditure, dietary intakes and 











































































































































































































































































































































































































































































































































































































































































































































































































































































Table 4.2 The total score and sub-score of Mini Nutritional Assessment in the 
CTL, the EAD and the LAD groups. 
CTL EAD LAD 
N=32 N=i9 N=25 p Value 
Mean ± S.D. Mean ± S.D. Mean 士 S.D.  
MNA score 27.3 ± 1.9 24.0 ±3.3 21.6 ±3.7 <0.001 
Anthropometric 6.7 ±1.5 6.2 ±2.0 5.7 ± 1.9 0.096 
General 8.8 ± 0.6 6.8 ±1.2 6.2 ±1.1 <0.001 
Dietary 8.2 ±0.5 7.8 ±1.1 7.4 ±1.1 0.006 
Self-esteem 3.6 士 0.6 3.2 ±0.7 2.4 ±1.1 <0.001 




Table 4.3 The dietary intake of the CTL, the EAD and the LAD groups. 
CTL EAD LAD 
N=36 N=18" N=24" 
Calories (Kcal) 1484 土 412 1602 土 570 1530 ±390 * 
二 丨 S 二 ） 26.4 ±8.1 51.7 ± 5.0 31.9 土 7.4 ** 
Protein (g) 68.0 ± 18.5 75.5 ±25.5 70.0 ±26.1* 
二 1 . 2 1 士 0.39 1.24 t 0.58 1.45 则 ** 
Carbohydrates (g) 201.6 土 66.8 206.8 士 71.7 205.9 ± 59.7 
Fat (g) 45.1 ± 16.3 52.8 ±25.1 * 47.6 土 18.2* 
Vitamin A (I.U.) 3525 ±3508 3501 +2896 1968 ± 1737 * 
Vitamin B1 (mg) 0.65 ±0.27 0.86 士 0.49 ** 0.65 ± 0.34 
Vitamin B2 (mg) 0.83 土 0.39 0.86 土 0.45 0.87 土 0.40 
Vitamin B3 (mg) 12.1 ±9.9 14.7 ±7.1 14.0 ±14.1 
Vitamin C (mg) 121.0 土 91.9 101.3 ±74.4 76.9 ±53.9 
Vitamin D (I.U.) 16.6 土 22.0 23.7 ±35.7 18.4 ±23.6 
Calcium (mg) 477.3 ± 199.5 428.1 ±206.2 464.7 ±284.9 
Phosphorus (mg) 812.0 ±261.3 835.1 ±326.0 805.1 ±342.0 
Iron (mg) 14.8 土 16.1 12.7 ± 5.3 16.2 土 19.8 
Cholesterol (mg) 231.8 土 125.2 2641.1± 112.9 245.8 土 103.0 
Fiber (g) 6.6 ±5.9 6.0 ±3.9 4.6 士 2.3 
Energy from (%) 
Carbohydrates 54.2 ± 7.0 51.7 土 5.0 54.2 ± 8.2 
Protein 18.5 ±2.5 19.0 ±2.6 18.2 ±3.7 
Fat 27.1 ±5.8 29.4 士 5.0 27.5 ± 5.9 
a Differences were observed taking the CTL group as reference, Univariate Analysis of Covariance with sex and age 




Table 4.4 Energy expenditure of the CTL, the EAD and the LAD groups. 
CTL EAD LAD 
Mean ± S.D. Mean ± S.D. Mean ± S.D.  
(N=35) (N=20) (N=24) 
RlVfR 
(kcal/day) 1119 土 141 1074 士 208 a 979 土 122 
S 二 • 19 .7 ,2 .6 19.7 士 2.6a , 0 . 7 . 3 . 3 
？ 二 二 ） 30.9 土 3.7 30.7 31 .6 .3 .8 
TDEE 
(kcal/day) 2223 ±434 1883 ±465* 1492 ±310*** 
TDEE/body weight 34 1 士 4 7*** 34 1 土 4 
(kcal/day/kg) ' 丄土斗•/ 土 
TDEE/LBM 61 4 士 9 2 52 4 土 7 52 4 ± 7 9*** 
(kcal/day/kg) 乂 )二辟 ^  “ 
"One missing value 
Differences were observed when taking the CTL group as reference, Univariate Analysis of Covariance with age and sex. 




Table 4.5 Correlations of percentage weight change over six months. 
Coefficient p value 
0.894 
Alzheimer's disease patient (Yes/No) 0.134 0.832 
MMSE -0.11 0.359 
BMI (kg/m2) -0.34 0.005 
Body Fat (o/o) -0.28 0.020 
Lean Body Mass (kg) -0.01 0.929 
Leptin (ng/ml) -0.19 0.123 
TNF (pg/ml) -0.16 0.196 
BMR/LBM (kcal/day/kg) 0.11 0.360 
TDEE/LBM (kcal/day/kg) -0.34 0.005 
Caloric Intakes / Body weigh (kcal/kg) 0.15 0.227 
Protein Intakes / Body weight (kcal/kg) 0.15 0.220 
Total score of MNA -0.31 0.010 




Table 4.6 Correlations between percentage weight change over six months and 
neuropsychiatric disturbances in Neuropsychiatric Inventory. 
Coefficient p Value 
Total score of NPI -0.12 
Delusion -0.34 0.004 
Hallucination -0.36 0.002 
Aggression -0.29 0.015 
Depression 0.054 0.659 
Anxiety 0.19 0.114 
Elation -0.07 0.566 
Apathy 0.02 0.864 
Disinhibition 0.09 0.453 
Irritability -0.18 0.138 
Aberrant Motor Problem -0.12 0.318 
Sleeping disorder 0.08 0.520 
Eating disorder OJ^ 0.123 




Fig. 4.1 Score of Mini Mental State Examination of the CTL, the EAD and the 
LAD groups. 
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Fig. 4.2 Classification of nutritional status by Mini Nutritional Assessment of the 
CTL, the EAD and the LAD groups. 
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Fig. 4.3 Plasma leptin levels per body fat mass of the CTL, the EAD and the LAD 
groups. 
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Fig. 4.4 Plasma TNF levels in the CTL, the EAD and the LAD groups. 
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Fig. 4.6 Percentage of weight change over six months in the CTL, the EAD and 
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No significant differences were observed, One Way ANOVA. 
82 
Results 
Fig. 4.7 Partial regression plot of percentage weight change against Total Daily 
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5.1 Nutritional Status 
Poor nutritional status was observed in the Late Alzheimer's disease (LAD) 
patients in both anthropometric measurements and Mini Nutritional Assessment. 
Moreover, clinical weight loss was more often occurred in the LAD patients than 
the CTL and the EAD subjects. However, there were also some LAD patients gain 
more than 5% of their weight over a period of six months. 
5.1.1 Cross-sectional Study 
Community dwelling Alzheimer's disease (AD) patients showed signs of 
poor nutritional status, especially in the late cases. For those subjects whose BMI 
was lower than the 25�卜 percentile of the reference BMI specific for age groups 
and gender were considered malnutrition. In the present study, the overall 
prevalence of malnutrition in the AD patients was 38% and as high as 70% being 
in the late stage. The rate of malnutrition according to the BMI in the AD patients 
was significantly higher than the CTL subjects. 
Consistent results with a higher rate of malnutrition in the LAD patients were 
also observed when evaluated by the Mini Nutritional Assessment (MNA). By 
MNA, the prevalence of malnutrition in community dwelling AD patients was 
11%. Out of the LAD patients, 18% of them were malnutrition. It should be 
noticed that about 48% of all AD patients in our study were under the 
classification of "at risk of malnourishment", with 54% of those at risk being in 
the LAD group. 
The body weight and BMI observed in the Late Alzheimer's disease (LAD) 
‘ patients was lower than the healthy elderly who served as Control (CTL), but 
there were no significant differences between the Early Alzheimer's disease (EAD) 
and the CTL groups. 
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A decrease in body weight in the AD patients is mainly due to the loss of 
body fat, which is a sign of energy deficiency, and it was observed that the LAD 
group had a lower body fat mass compared to the CTL group. When subjects are 
suffering from energy imbalance, their metabolism will switch to using body fat 
as a major fuel for energy. Therefore lower body fat mass is always observed in 
energy malnutrition patients. 
There were no significant differences observed in lean body mass between 
three groups though there was a trend that the LAD group had a lower lean body 
mass. It revealed that the loss of LBM was the secondary cause of decreased body 
weight in the LAD patients. 
The results found in this study of Alzheimer's disease patients at a late stage 
were consistent with previous studies where body weight and BMI were lower 
than cognitively normal elderly. A study on 23 institutionalized AD patients and 
28 cognitively normal elders revealed that both male and female patients with AD 
weighed less and had lower BMI than cognitively normal elders (Renvall et al., 
1993). 
In short, Chinese AD patients have poor nutritional status, especially those in 
the late stage of AD. This problem should be addressed to their caregivers in order 
to prevent further deterioration. 
5.1.2 Longitudinal Observations 
The incidence of clinical weight loss in this study of AD patients was 14%. 
And out of the LAD patients, 21% of them experienced clinical weight loss. 
These results were consistent with those from the MNA which revealed that about 




The nutritional problem of AD patients may not be unrectifiable. Although, 
there was a higher frequency of clinical weight loss in the LAD patients, some of 
the LAD patients gained more than 5% of their weight in a period of six months. 
It implied that the LAD patients were capable to gain weight. 
Although there was no significant difference in average weight change over 
six months between the CTL, the EAD and the LAD groups, the weight of the 
LAD patients showed more changes in both directions then the CTL and the EAD 
groups. This implied that there might be a body weight dysregulation in the LAD 
patients. 
Neither the presence of Alzheimer's disease nor the severity significantly 
correlated with weight change. They were not significant predictors of weight 
change in the multiple linear regression model. The nutritional problems 
encountered in the AD patients might not due to the disease itself, but might be 
related to other features associated with AD. 
In order to gain insight on weight change in the AD patients at the late stage, 
the characteristics of the 3 top weight gainers and weight losers were examined. 
The top weight gainers had lower BMI (BMI: 12.96kg/m^ 19.40kg/m^ 
19.46kg/m^) at basline and lived with supportive family. They gained weight 
probably because their caregivers had increased the awareness of their nutritional 
problems after participating the study. The top weight losers suffered severe 
psychotic disturbances revealed by the NPI (The total score of NPI: 124, 68, 44). 
Psychotic behaviors might increase energy expenditure in AD patients and 
negatively affect the caring capacity of caregivers, resulting in weight loss in the 
4 
AD patients. The significance of psychotic symptoms in the weight loss in the AD 
patients will be discussed later. 
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5.2 Factors associated with Nutritional Status 
5.2.1 Biological factors 
Dietary Intake 
In this present study, no strong evidence supported that poor nutritional status 
was associated with inadequate dietary intake. There were no significant 
differences in the intake of calories, macronutrients, minerals and vitamins were 
observed between the CTL, the EAD and the LAD groups. The proportion of 
energy from the three macronutrients, carbohydrate, protein and fat, was 
appropriate among three groups. Both the EAD and the LAD patients even 
showed better dietary intake than the CTL subjects, in terms of caloric and protein 
intake when adjusted with their body size. This indicated that poor nutritional 
status was not related to poor dietary intake in AD patients. A previous study 
showed similar findings. Sandman et al” (1987) reported that institutionalized AD 
patients had adequate energy and protein intake, but even in the malnourished AD 
patients. Another study on institutionalized AD patients showed that they had 
higher energy and protein intake than the cognitive intact subjects did (Spindler et 
al.，1996). 
Additionally, a higher caloric and protein intake observed in the AD patients 
in the present study may imply that their caregivers had recognized the patients' 
nutritional problems, and hence paid more attention on their dietary intakes. 
There are some limitations in estimating the subjects' dietary intake by using 
the three days dietary record. In this present study, some subjects in the CTL 
group recorded their dietary intake by themselves and they may under report their 
consumptions if they were health concern. While the dietary records of AD 
patients were completed by their caregivers who might have over-reported or 
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encouraged the patients to eat more, as a consequence of increased awareness of 
nutritional adequacy. Therefore, the results of the dietary records might have been 
biased to a certain extent. 
Enersv expenditure 
Basal Metabolic Rate (BMR) 
Poor nutritional status was not associated with elevated energy expenditure, 
like，basal metabolism or total daily energy expenditure. Results showed that there 
were no significant differences of BMR between the CTL, the EAD and the LAD 
groups, even when adjusted with their body size or lean body mass. In short, 
BMR was not altered by the disease and was appropriate for their metabolic size 
of the well-nourished AD patients, and even patients at late stage with poor 
nutritional status. Previous studies on community dwelling AD patients also 
observed a similar level of resting metabolic rate by indirect calorimeter as 
healthy elderly. However, since the AD group in the study had a similar 
nutritional status as the healthy elderly, little was known about the basal 
metabolism in AD patients with poor nutritional status (Donaldson et al., 1996). 
Total Daily Energy Expenditure (TDEE) 
In cross sectional comparison, elevated TDEE was unlikely to be one of the 
causes contributed to poor nutritional status in the AD patients. On the contrary, 
both the EAD and the LAD groups were lower in TDEE, which was measured by 
a Physical Activity Questionnaire. AD patients, due to their impaired cognition, 
seldom do housework. They also tend to lose their initiation, or interest, to join 
i 
leisure activities. Therefore, the AD patients had a lower physical activity level 
and a lower TDEE as a consequence. 
Lower TDEE in the AD patients was also observed in previous studies. One 
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Study determined TDEE by doubly labeled water, observed that the TDEE was 
14% lower in AD patients because of lower resting expenditure and physical 
activity, but no differences were observed after controlling for body composition. 
Similar findings were observed in another study when cachectic AD patients and 
non-cachectic subjects were compared (Poehlman et al., 1997). These findings 
were consistent with ours. 
Lower physical activity level accelerates the loss of lean body mass, which 
might be the secondary cause of weight loss in the AD patients (Khodeir et al., 
2000; Miziniak, 1994). A previous study showed that higher levels of physical 
activity were associated with higher appendicular skeletal muscle mass in 30 
noninstitutionalized AD patients (Dvorak & Poehlman，1998). Therefore 
caregivers should encourage them to do more exercise to retain their lean mass. 
The limitation of using the PAQ to estimate TDEE was that energy 
expenditure on some activities was excluded, like agitation. The technique of 
doubly labeled water or direct calorimeter, which are the golden standards in 
measuring TDEE, are able to overcome this limitation. But both methods are 
expensive and difficult to perform reliably. The latter is impossible in demented, 
because it involves confining them in an unfamiliar and small environment. 
From the longitudinal observations of the present study, however, the TDEE 
was negatively correlated with the percentage weight change over six months 
among the AD patients. This implied that the relatively active AD patients were 
more likely lose weight, which contrasts with the clinical impression of frail 
immobile demented older patients wasting away in nursing homes. The present 
< 
sample consisted of the AD outpatients who were still capable of being looked 
after in the community, and with good family support. In this situation, it appeared 
that the physically inactive and well-fed AD patients gained weight, whereas the 
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more active are at risk of losing weight. 
If weight loss in the active AD subjects was related to energy imbalance, the 
energy intake could be expected to correlate with weight change. But it did not 
appear to the case on further analysis. This could be explained by the high level of 
compliance required to keep a reliable food record, and the possibility that dietary 
pattern changed significantly while the food intake was observed. In addition, the 
estimated TDEE by the PAQ was also subject to inaccuracies on the individual 
level (Liu et al, 2001). 
Nevertheless, the most likely explanation is that appetite regulation was 
impaired in the AD patients. Appetite regulation has been shown to decrease in 
old age (Poehlman, 1992). No formal evaluation on appetite regulation in AD 
patients has been done on literature review. But eating disorders in AD patients 
are well described. For example, hyperphagia occurred in up to a quarter of AD 
patients, usually at its middle stage. In the late stage, multiple problems, e.g. 
dysphagia, apraxia, mood instability, communication problems, all contribute to 
poor oral intake. 
Olfactory function 
AD patients, both in the early and the late stage, showed that they had poor 
olfactory functions. Their performance was poor in the Olfactory Identification 
Test and had a higher threshold for detecting smell than the CTL group. Although 
the olfactory function plays an important role in the comfort of food, no 
association between dietary intake and olfactory function were observed in this 
present study. It may be because there are many factors that affect one's dietary 
intake, like the encouragement from caregivers, and the olfactory function only 
has a minor effect on it. Additionally, the degree of olfactory loss in AD patients 
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might be mild which would not influence their enjoyment on food. None of the 
AD patients in the present study had their olfactory function completely lost. 
Previous studies have also revealed that AD patients suffer from olfactory 
impairment (Bums, 2000; Murphy, 1993; Rezek, 1987; Schiffinan, 1993)，but the 
causes of it have not yet been identified. One assumption that has been postulated 
is related to the degeneration of the brain in the area that responds to olfactory 
functions. The effects of olfactory function loss on dietary intake in the AD 
patients have not been studied before. In the present study, the AD patients with 
olfactory dysfunction did not decrease their dietary intake, thus olfactory 
dysfunction is not likely to be a direct causative factor affecting nutritional status. 
5.2.2 Biochemical factors 
Leptin 
There was some evidence that the regulation secretion was impaired in the 
LAD patients. As expected the plasma leptin levels correlated significantly with 
body fat mass in the CTL and the EAD groups. However, the correlation became 
much weaker and insignificantly in the LAD subjects. There were a few LAD 
subjects who had elevated plasma leptin levels relative to body fat mass. This 
implied the central leptin regulation via the hypothalamus was impaired. The 
higher productivity of leptin from the adipose cells may be explained by the 
resistance to leptin of the specific receptors in the hypothalamus, which hence 
increased the expression of the obese gene in adipose cells. This hypothesis 
remains controversial. 
‘ In addition, there were no significant differences in plasma leptin levels per 
body fat mass among the CTL, the EAD and the LAD groups. The lack of 
correlation between plasma leptin levels and body fat mass in the LAD group 
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suggested that a higher secretion of leptin per fat cell was not a feature 
consistently associated with AD, but may occur in some AD patients. 
Leptin has been suggested to be a key modulator of appetite, but none of 
previous reports explained the relation between the energy intake and leptin levels 
of the elderly. No evidence from this present study supported that leptin is able to 
affect the dietary intake and nutritional status, since the plasma leptin levels did 
not correlate with the dietary intake in both the healthy elderly and the AD 
patients. Moreover, the self-reported appetite over past three months in Mini 
Nutritional Assessment (MNA) was not correlated with plasma leptin levels. Few 
studies explored the leptin and appetite of cachectic subjects. One of the studies 
on women with moderate energy deficits showed that leptin was associated with 
self-reported hunger and the prospective consumption (Keim et al., 1998). There 
was a bit different from our findings. The evidence that leptin is an important 
determinant of appetite in humans is so far uncertain. 
There were no effects of leptin on basal metabolism in either of the healthy 
elderly or the AD patients. No correlation between plasma leptin levels and BMR 
were found among the three groups in the present study. Previous findings on 
leptin and energy expenditure were inconsistent. Two studies on healthy elderly 
subjects reported that leptin levels were not correlated with resting metabolic rate 
(Neuhauser-Berthold et al, 2000) or BMR (Toth et aL, 1997)，and these were 
consistent with our findings on healthy elderly. On the other hand, some studies 
reported that leptin levels were well correlated with BMR in patients with 
anorexia nervosa or chronic heart failure (Polito et al., 2000; Toth et al.’ 1997). It 
< 
is suspected that leptin is able to influence BMR when patients suffer severe 
malnutrition, like anorexia nervosa. In the present study, there was no correlation 
between the leptin and BMR in the AD patients, which might be because their 
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nutritional problems were mild to moderate only, the severe cachectic AD patients, 
usually are the nursing home residents or their general conditions are poor, were 
excluded in this present study. In addition, the response to leptin in the AD 
patients has not been assessed. Leptin produced from the adipose cells, then enter 
blood steam and reach the hypothalamus. When the hypothalamus received the 
signals of leptin and hence decreased the secretion of Neuropeptide Y，resulting in 
an increase in the Basal Metabolic Rate. If the feedback loop does not work 
properly, leptin cannot influence BMR and hence no correlation between leptin 
and BMR was found. 
Tissue Necrosis Factor (TNF) 
Alzheimer's disease was suspected to be a wasting process, because the brain 
degeneration in AD patients involves inflammation. However, this Hypothesis 
was not supported by this present study, since the plasma level of the TNF, an 
indicator of wasting process, did not differ between the CTL, the EAD and the 
LAD groups. Additionally, the plasma TNF levels were correlated with neither 
body weight nor BMI. This contrasted with another study which reported that the 
TNF levels in AD patients were higher than other psychiatric patients (Fillit et al” 
1991). It should be noted that the plasma TNF levels were raised in a number of 
the CTL subjects. The plasma TNF levels have been known to be raised in a 
variety of medical conditions, like patients with Chronic Obstructive Airway 
disease. A bigger control group and screening for underlying medical diagnoses 
which may influence the plasma TNF levels are required to make a more valid 
comparison. In addition, the inflammatory process in the AD patients was 




In this present study, plasma TNF levels were not associated with the plasma 
leptin levels of both the healthy elderly and the AD patients. It has been suggested 
that the TNF initiated a wasting process which affected leptin levels. A previous 
study on patients with solid tumor showed that the TNF infusion increased plasma 
leptin level (Zumbach et aL, 1997). However, another study on patients with 
chronic obstructive pulmonary disease demonstrated similar findings as ours, that 
TNF levels were not correlated with leptin (Takabatake et al., 1999). The relations 
between TNF and leptin remain unclear. 
5.2.3 Psychosocial factors 
Neusopsychiatric disturbances 
Behavioral problems, especially those that are aggressive behavior, might 
have contributed to poor nutritional status in AD patients. There were no 
differences of the total score of NPI between the EAD and the LAD groups. 
Additionally, not many of the AD patients who scored highly on the NPI total 
score. The most likely reason is that there has been some selection bias, since the 
psychotic symptoms might have been controlled by medication and the severe 
cases would no longer be community dwelling. 
Among the eleven domains, only the subscore of aberrant motor problem 
was higher in the LAD than the EAD subjects while there were no differences in 
the other. Up to 60%of the LAD subjects and 30% of the EAD subjects reported 
aberrant motor behavior. Ambulatory AD patients, especially when they were in 
the moderate to late stage, may pose an increased burden to the caregiver, which 
‘ might decrease the quality of care. Moreover, the aberrant motor behavior, like 
walking around, might also increase energy expenditure. These all may be 
resulting in a poor nutritional status on AD patients. However, in this present 
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Study, the relationship between aberrant motor behavior, energy expenditure and 
nutritional status could not be properly evaluated, since TDEE was estimated by 
Physical Activity Questionnaire which is not able to estimate the energy 
expenditure on the aberrant motor behavior. 
There was no correlation between the NPI total score or subscore and 
nutritional status in the AD patients cross sectionally. This was consistent with a 
recent local study. Pang (2001) ran a study on 51 institutionalized, demented 
patients with neuropsychiatric symptoms were evaluated by the NPI. No 
significant associations were found between the NPI total score and nutritional 
parameters, like BMI and plasma albumin levels. However, the power of that 
study was not large enough to disprove the relationship between neuropsychiatric 
disturbances and nutritional status. 
From the longitudinal observations in the present study, delusion, 
hallucination and aggression promoted weight loss. Among the twelve 
neuropsychiatric behaviors in NPI, only these three domains were negatively 
correlated with percentage weight change over six months. Subjects who 
experienced delusion, hallucination and aggression were in distress and might 
have a higher BMR. However, the higher BMR could not be revealed by the 
indirect calorimeter measurement, since they were calm during the assessment, 
and the fluctuations in reading were omitted. 
This was consistent with another study of the AD nursing home residents in 
US showing an inverse correlation between the total score of NPI and weight loss 
over six months (White et al.，2001). 
< 
Among the twelve domains in the NPI, the subscore of hallucination was 
found to be the strongest predictor of weight change over six months. 
Hallucination, on its own, could not explain its effect on weight change. It should 
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be addressed that subjects who experienced hallucinations, frequently also 
suffered other neuropsychiatric behaviors, like irritability. Also, it can indirectly 
cause agitation, insomnia and poor appetite. Moreover caregivers stress might 
result in suboptimal care. 
Burden of caregivers 
In a recent study, AD patients with caregivers who experienced high stress 
had a greater weight loss this might be due to a poor quality of care，like diet 
preparation (Gillette-Guyonnet et al, 2000). Unfortunately, it was not examined 
in the present study. However, as most carers were believed to have a positive 
attitude, since they all consented to participate in this study. 
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In this present study, a higher prevalence of malnutrition was observed in the 
AD patients, especially those in the late stage of disease. There was no evidence 
that basal metabolic rate and TNF levels were altered in AD. There was some 
evidence that regulation of leptin was impaired in late AD subjects, but its 
significance on dietary intake or nutritional status was not apparent. The dietary 
intakes of the AD subjects appeared to be comparable to normal controls, despite 
some methodological limitations. 
The most significant finding of this study was that the weight changed more 
markedly in late AD subjects. They were as liable to gain weight as to lose weight. 
This strongly suggested that their regulation of appetite was more impaired than 
normal elderly. In such situation, the total energy expenditure clearly became an 
important determinant of nutritional status. 
It is very difficult to estimate Total Daily Energy Expenditure (TDEE) 
reliably, not least in AD patients. Despite the limitation of a simple physical 
activity questionnaire, increased TDEE was shown to correlate with weight loss. 
The significance of this observation is that caregivers should monitor the weights 
of AD patients and adjust the nutritional values of foods offered to them according 
to their activity levels. Dietary advice on AD patients who are losing or gaining 
weight may be warranted. It must be emphasized that increased physical exercise 
in AD patients have many benefits both physically and mentally (Miziniak, 1994). 
AD patients should therefore be encouraged to remain as active as possible. But 
dietary intake has to be increased accordingly. 
Another contribution of this study was that psychotic symptoms like 
hallucination have significant impact on the nutritional status of AD patients. 
Apart from this consideration, they have major impact on the quality of life of 
patients and their caregivers. They should therefore be enquired about and treated 
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as much as possible. 
Lastly, it has to be pointed out that this group of AD patients was selective in 
that they were well looked after by family caregivers. With the impaired 
regulation of appetite in AD patients, they can be expected to be at great risk of 
malnutrition if they do not receive adequate care, especially in its late stage, when 
caring can become extremely burdensome. At the final stage of the disease, 
enteral feeding will almost inevitably become a major ethical dilemma for family 
and formal caregivers alike. 
Limitations and future research 
In another investigation of risk factors, cross sectional studies are often 
subjected to the influences of confounders and selection bias. It is therefore 
preferably to use the prospective design. The emphasis of this study was on the 
cross sectional comparison. Consequently, the follow-up period of six months was 
relatively short and only weight was measured. As results unfolded, the limited 
prospective element appeared to be more useful. Attempt was made to further 
follow-up the subjects at twelve months. But there were too many loss of 
follow-up, on the ground of admission to nursing homes or refusal. A longer 
cohort study of early AD patients focusing on dietary intake, physical activity 
level and psychotic symptoms is needed to confirm the findings of this study. In 
order to improve compliance and prevent loss of follow-up, the amount of 
investigations may have to be curtailed. The appetite regulation of AD patients 
and the energy expenditure of AD patients with psychotic symptoms are specific 
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Appendix 1 Clinical Diagnosis of Alzheimer's disease 
I The criteria for the diagnosis of motor signs such as increased muscle tone, 
PROBABLE Alzheimer's disease include: myoclonus, or gait disorder; 
dementia established by clinical examination and seizures in advanced disease: and 
documented by the Mini-Mental Test, Blessed 
Demntia Scale, or some similar examination, and CT normal for age. 
confirmed by neuropsychological tests; 
IV Features that make the diagnosis of 
deficits intwo or more areas of cognition: PROBABLE Alzheimer's disease uncertain or 
unlikely include: 
progressive worsening of memory and other 
cognitive functions; sudden, apoplectic onset; 
no disturbance of consciousness; 
focal neurologic findings such as hemiparesis, senory 
onset between ages 40 and 90，most often after age 65; loss, visual field deficits, and incoordination early in 
and the course of the illness. 
absence of systemic disorders or other brain diseases seizures or gait disturbances at the onset or very early 
that in and of themselves could account for the in the course of the illness, 
progressive deficits in memory and cognition. 
V Clinical diagnosis of POSSIBLE 
n The diagnosis of PROBABLE Alzheimer's Alzheimer's disease: 
disease is supported by: 
may be made on the basis of the dementia syndrome, 
progressive deterioration of specific cognitive in the absence of other neurologic, psychiatric, or 
functions such as language (aphasia), motor skills systemic disorders sufficient to cause dementia, and 
(apraxia), and perception (agnosia); in the presence of variations in the onset, in the 
presentation, or in the clinical course; 
impaired activities of daily living and altered patterns 
of behaviors; may be made in the presence of a second systemic or 
brain disorder sufficient to produce dementia, which 
family history of similar disorders, particularly if is not considered to be the cause of the dementia; and 
confirmed neuropathologically; and 
should be used in research studies when a single, 
laboratory results of: gradually progressive severe cognitive deficit is 
identified in the absence of other identifiable cause. 
normal lumbar puncture as evaluated by 
standard techniques, VI Criteria for diagnosis of DEFINITE 
Alzheimer's disease are: 
normal pattern or nonspecific changes in EEG, 
such as increased slow-wave activity, and the clinical criteria for probable Alzheimer's disease 
and histopathologic evidence obtained from a biopsy 
evidence of cerebral atrophy on CT with or autopsy, 
progression documented by serial observation. 
Vn Classiflcation of Alzheimer's disease for 
m other clinical features consistent with the research purposes should specify features that 
diagnosis of PROBABLE Alzheimer's disease, may differentiate subtypes of the disorder, such 
after exclusion of cause of dementia other than as: 
Alzheimer's disease, after exclusion of cause of 
dementia other than Alzheimer's disease, include: familial occurrence; 
plateaus in the course of progression of the illness; 
onset before aged of 65; 
associated symptoms of depression, insomnia, 
incontinence, delusions, illusions, hallucinations, presence of trisomy-21; and 
catastrophic verbal, emotional, or physical outbursts, 
‘ sexual disorders, and weight loss; coexistence of other relevant conditions such as 
Parkinson's disease. 
other neurologic abnormalities in some patients, 
especially with more advanced disease and including 
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Appendix 2 Consent Form 
The Chinese University of Hong Kong 
Department of Medicine and Therapeutics 
The Nutritional assessment on Elderly 
I ，I/D no.: hereby consent to 
participate in this research study which includes the following assessments: 
1. 3 days dietary record. 
2. Questionnaires. 
3. Weight, Height and Fat Content Measurements 
4. Clinical assessments, includes Basal Metabolic Rate Measurement, 
Plasma leptin (a hormone related to obesity) determination, body 
temperature record and taste sensation test. 
5. Follow up reassessment after 6 months. 
I understand the purposes, assessments and methods in this research and 
know that I can withdrawal or terminate whenever I encounter any problem or feel 
uncomfortable during assessment. This will not affect the treatment that I received. 
I understand my participation is entirely voluntary. The information will be 
kept strictly confidential and will be used for statistical purpose. 
Signature: (Participant) 




The Chinese University of Hong Kong 
Department of Medicine and Therapeutics 
The Nutritional assessment on Alzheimer's Disease patients 
I ，I/D no.: hereby consent to 
participate in this research study which includes the following assessments: 
1. 3 days dietary record. 
2. Questionnaires. 
3. Weight, Height and Fat Content Measurements 
4. Clinical assessments, includes Basal Metabolic Rate Measurement, Plasma 
leptin (a hormone related to obesity) determination, body temperature record 
and taste sensation test. 
5. Follow up reassessment after 6 months. 
I understand the purposes, assessments and methods in this research and 
know that I can withdrawal or terminate whenever I encounter any problem or feel 
uncomfortable during assessment. This will not affect the treatment that I received. 
I understand my participation is entirely voluntary. The information will be 
kept strictly confidential and will be used for statistical purpose. 
Signature: (Participant) 





香 港 中 文 大 學 
內 科 及 藥 物 治 療 科 
老 人 之 營 養 狀 況 調 査 
本 人 ， 身 份 證 號 碼 ： 
同 意 參 加 這 次 硏 究 ， 檢 查 內 容 包 括 ： 
1. 3 日 膳 食 記 錄 
2 . 問 卷 調 查 
3 . 身 高 、 體 重 及 脂 肪 含 量 量 度 
4 . 臨 床 檢 查 ， 包 括 基 本 代 謝 率 檢 定 ， L e p t i n (與肥胖有關 
的 荷 爾 蒙 ） 血 液 含 量 ， 體 溫 記 錄 和 味 覺 測 試 
5 . 於 六 個 月 後 再 接 受 檢 查 
本 人 淸 楚 是 次 硏 究 的 目 的 、 檢 查 內 容 及 方 法 。 本 
人 若 遇 到 任 何 疑 問 或 於 檢 查 時 感 到 不 適 ， 可 隨 時 提 出 
或 退 出 ， 而 絕 不 影 響 所 接 受 的 診 治 。 
本 人 明 白 本 人 參 與 此 硏 究 是 自 願 的 。 所 有 資 料 絕 
對 保 密 ， 並 只 作 統 計 用 途 。 
簽署： (參加者） 





香 港 中 文 大 學 
內 科 及 藥 物 治 療 科 
老 人 痴 呆 症 患 者 之 營 養 狀 況 調 查 
本 人 ， 身 份 證 號 碼 ： 
同 意 參 加 這 次 硏 究 ， 檢 查 內 容 包 括 ： 
1. 3 日 膳 食 記 錄 
2 . 問 卷 調 查 
3 . 身 高 、 體 重 及 脂 肪 含 量 量 度 
4 . 臨 床 檢 查 ， 包 括 基 本 代 謝 率 檢 定 ， L e p t i n (與肥胖有關的荷 
爾 蒙 ） 血 液 含 量 ， 體 溫 記 錄 和 味 覺 測 試 
5 . 於 六 個 月 後 再 接 受 檢 查 
6. 
本 人 淸 楚 是 次 硏 究 的 目 的 、 檢 查 內 容 及 方 法 。 本 
人 若 遇 到 任 何 疑 問 或 於 檢 查 時 感 到 不 適 ， 可 隨 時 提 出 
或 退 出 ， 而 絕 不 影 響 所 接 受 的 診 治 。 
本 人 明 白 本 人 參 與 此 硏 究 是 自 願 的 。 所 有 資 料 絕 
對 保 密 ， 並 只 作 統 計 用 途 。 
簽署： (參加者） 





Appendix 3 Mini Nutritional Assessment 
Case No.:  
Total Score:  
MINI NUTRITIONAL ASSESSMENT (MNA) 
Please answer the following questions and circle the most suitable answer in for 
you. Thankyou! 
Anthropomtric Assessment 
1. Body Mass Indx (BMI) (weight in kg)/(height in m^) 
a. BMI <19 (0 points) 
b. BMI 19 to <21 (1 points) 
c. BMI 21 to <23 (2 points)  
d. BMI > 23 (3 points) 
2. Mid-arm circumference (MAC) in cm 
a. MAC <21 (0.0 points) 
b. MAC 21 < 22 (0.5 points) 
c. MAC >22 (1.0 points) 
3. Calf circumference (CC) in cm 
a. C C < 3 1 (0 points)  
b. C C > 3 1 (1 points) 
4. Weight loss during last 3 months 
a. weight loss greater than 3 kg (6.61bs) (0 points) 
b. does not know (1 points) 
c. weight loss between 1 and 3 kg (2.2 and 6.6 lbs) (2 points)  
d. no weight loss (3 points) 
General Assessment 
5. Lives independently (not in a nuring home or hospital) 
a. no (0 points)  
b. yes (1 points) 
6. Takes more than 3 prescriation drugs per day 
a. yes (0 points)  
b. no (1 points) 
7. Has suffered osychological stress or acute disease in the past 3 months 
a. yes (0 points)  




a. bed or chair bound (0 points) 
b. able to get out of bed or chair but does not go out (1 points)  
c. goes out (2 points) 
9. Neuropsychological problems 
a. severe dementia or depression (0 points) 
b. mild dementia (1 points)  
c. no psychological problems (2 points) 
10. Pressure sores or skin ulcers 
a. yes (0 points)  
b. no (1 points) 
Dietary Assessment 
11. How many full meals does the patients eat daily? 
a. 1 meal (0 points) 
b. 2 meals (1 points)  
c. 3 meals (2 points) 
12. Selected consumption markers for protein intake 
At least one serving of dairy products (milk, cheese, yogurt) per day? 
( l)yes (2) no 
Two or more serving of legumes or eggs per week? 
(1) yes (2) no 
Meat, fish or poultry every day? 
(1) yes (2) no 
a. if 0 or 1 yes = 0.0 points 
b. if 2 yes = 0.5 points  
c. if 3 yes = 1.0 points 
13. Consumes two or more servings of fruits or vegetables per day? 
a. no (0 points) 
b. yes (1 points) 
14. Has food intake declining over the past three months due to loss of appetite, 
digestive problems, chewing or swallowing difficulties? 
a. severe loss of appetite (0 points) 
b. moderate loss of appetite (1 points) 
c. no loss of appetite (2 points) 
15. how much fluid (water, juice, tea, coffee, milk,...) is consumed per day? 
(1 cup = 8 oz.) 
a. less than 3 cups (0.0 points) 
b. 3 to 5 cups (0.5 points)  
c. more than 5 cups (1.0 points) 
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16. Mode of feeding 
a. unable to eat without assistance (0 points) 
b. self-fed with some difficulty (1 points) 
c. self- fed without any problem (2 points) 
Self Assessment 
8. Do they view themselves as having nutritional problems? 
a. major malnutrition (0 points) 
b. does not know or moderate malnutrition (1 points)  
c. no nutritional problem (2 points) 
17. In comparison with other people of the same age, how do they consider their 
health status? 
a. not as good (0.0 points) 
b. does not know (0.5 points) 
c. as good (1.0 points)  
d. better (2.0 points) 
Assessment Total (max. 30 points) 
Malnutrition Indicator Score: ^ 24 points well-nourished • 
17 to 23.5 points at risk of malnutrition 口 
<17 points malnourished 口 
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Appendix 4 Mini Mental State Examination 
簡短智能測驗 
最高分數分數 
5 ( ) 依家係ti野日子？(年份、季節、月份、幾號、星期幾） 











5 ( ) 請你用一百減七’然後再減七’一路減落去，直至我叫你停爲止。 
(減五次後便停） ( ) 
或：依家我讀幾個數目俾你聽’請你倒轉頭講番出黎。 
[ 4 2 7 3 1] ( ) 
3 ( ) 我頭先叫你記住既三樣野係"t^野呀？ 





e .請你講任何一句完整既句子俾我聽° (1) 
如：〔我係一個人〕、〔今日天氣好好〕 
f. 哩處有幅圖，請你照住呢畫啦° (1) 
總分: 
丰白手 pO 




Appendix 5 Functional Assessment Staging (FAST) 
Functional Assessment Staging (FAST) 
Check highest consecutive level of disability 
Subject's name : Ref ID: Stage:  
1. No difficulty, either subjectively or objectively. 
2. Complaints of forgetting location of objects. Subjective work difficulties. 
3. Decreased job functioning evident to co-workers. Difficulty in traveling to new locations. 
Decreased organizational capacity. * 
4. Decreased ability to perform complex tasks, e.g. planning dinner for guests, handling personal 
finances (such as forgetting to pay bills), difficulty marketing, etc. * 
5. Requores assistance in choosing proper clothing to wear for the day, season, or occasion, e.g. 
patient may wear the same clothing repeatedly, unless supervised * 
6 (a) Improperly putting on clothes without assistance or cuing (e.g. may put street clothes on 
over night clothes, or put shoes on wrong feet, or hve difficulty buttoning clothing) 
occasionally or more frequently over the past weeks. * 
(b) Unable to bathe properly (e.g. difficulty adjusting bath-water temperature) occasionally or 
more frequentl over the past weeks. 
(c) Inability to handle mechanics of toileting (e.g. forgets to flush the toilet, does not wipe 
properly or properly dispose of toilet tissue) occasionally or more frequently over the past 
weeks. * 
(d) Urinary incontinence (occasionally or more frequently over the past weeks). * 
(e) Fecal incontinence (occasionally or more frequently over the past weeks). • 
7 (a) Ability to speak limited to approximately a half a dozen intelligible different words or 
fewer, in the course of an average day or in the course of an intensive interview. 
(b) Speech ability limited to the use of a single intelligible word in an average day or in the 
course of an intensive interview (the person may repeat the word over and over). 
(c) Ambulatory ability lost (cannot walk without personal assistance). 
(d) Cannot sit up without assistance (e.g. the individual will fall over if there are no lateral rests 
[arms] on the chair). 
(e) Loss of ability to smile. 
(f) Loss of ability to hold up head independtly. 
•Scored primarily on the basis of information obtained from a knowledgeable informant and/or 
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Appendix 6 Physical Activity Questionnaire (PAQ) 
Physical Activity Questionnaire 
Name : Ref. No. : 
Date : Age : M/F 
Height : (cm) Weight : 
(kg) 
Health status : Contact no. : 
Chinese University of Hong Kong Department of Medicine and Therapeutics are interested 
in your regular work and leisure routines. Here is list out common types of physical 
activities (including occupational and leisure time activities) Please tell me which of them 
you did during the last week and for each activity you do, please tell me how much time 
(hours) you spent in that activity each time. (N.B. If the last week isn't a typical week of 
you, please use a usual week as reference) 
Example: 
If I swim 2 times a week and 1 hour each time (excluding changing clothes), I should record 
like this:  
Duration for each Frequency per 
time (hr) week 
(times/week) 
V Swimming 1 hr 2 times 
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Are you working now? Yes (pis. specify)  
No (if N, pis. go to pg.3) 
How many days did you work for last week? Days 
Each day hr 
Research use only  
Hour(s) spent for Intensity 
Each time code 
(kcal/min) 
A. Occupation 
1 • Sitting while working hr 1.7 
e.g. typing, writing 
2. Standing while working hr 2.0 
e.g. selling, teaching 
3. Moving while working hr 3.5 
e.g. patrolling 
4. Loading while working hr 8.5 
e.g. machinery 
What kind of transportation you usually takes while you goes to and from work? 
To work : 
From work : 
Travelling time for to and from work? 
To work : (min) From work: (min) 1.45 
Walking time between transportation and to and from work? 




How many hours you usually sleep for a usual day? hr 
Hour(s) spent for Frequency Intensity 
Each time per week code  
(kcal/min) 
B. General activity 
1. Shopping (eg. Grocery, clothes, food) hr times 3.5 
2. Transportation other than go to and from hr times 1.45 
work 
3. Stair climbing while carrying a load hr times 8.5 
4. Laundry (hanging, folding, ironing) hr times 3.0 
5. Light housework : tidying, dusting, hr times 3.0 
sweeping, collecting trash in home 
6. Heavy housework : vacuuming, hr times 4.5 
mopping, scrubbing floors etc 
7. Food preparation & service hr times 2.5 
(+ lOmins):chopping, setting table etc 
8. Cooking hr times 2.7 
9. Dish washing (+10mins): hr times 2.5 
clearing table; washing dishes 
10. Light Home repair : small appliance hr times 3.0 
repair; light home maintenance 
11. Heavy home repair: painting, hr times 5.5 
carpentry, washing/polishing car 
12. Eating (all meals) hr times 1.38 
13. Other (pis. specify) hr times 
Sub-total  
C. Care-taking Hour(s) spent for Frequency Intensity 
Each time per week code 
(kcal/min) 
1. Older or disabled person (lifting, pushing hr times 5.5 
wheelchair etc.) 
2. Childcare (lifting, carrying, pushing hr times 4.0 
stroller, bathing etc.) 
— 3 . Pet caring hr times 1.8 
4. Others (pis. Specify) hr times 
Sub- total  
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Hour(s) spent for Frequency Intensity 
Each time per week code 
(kcal/min) 
Exercise 
(N.B. excluding times for changing cloth)  
1. Brisk walk (+10 mins) hr times 6.0 
2. Stretching exercise: hr times 3.0 
Yoga; Tai-qi; Qi Kung; stretching 
3. Vigorous calisthenics, aerobics hr times 6.0 
4. Dancing (mod/fast): ballroom, hr times 5.5 
Chinese dancing 
5. Bowling hr times 3.0 
6. Ping Pong hr times 4.0 
7. Racquet sports: tennis, racquet ball hr times 7.0 
— 8 . Golf hr times 5.0 
9. Bocci hr times 2.5 
10. Cycling, exercycle hr times 6.0 
11 • Swimming hr times 6.0 
一 12. Volley ball hr times 4.0 
— 1 3 . Basketball hr times 7.0 
一 14. Football hr times 8.0 
15. Squash hr times 11.4 




Hour(s) spent for Frequency Intensity 
Each time per week code 
(kcal/min) 
E. Leisure activities 
1. Leisurely walking (+10 mins) hr times 3.5 
2. Needle work: knitting, sewing, hr times 1.5 
needlepoint etc. 
3. Fishing hr times 3.5 
4. Playing musical Instruments hr times 2.9 
5. Writing, Drawing hr times 1.7 
6, Singing: Chinese Opera, Karoake hr times 2.4 
7. Playing chess, mar-jong or cards hr times 1.5 
8. Watching TV, Listening to Radio hr times 1.3 
9. Reading: newspaper, magazine, books hr times 1.3 
10. Using computer hr times 1.6 
11. Leisurely sitting hr times 1.3 
12. Religious activity hr times 1.3 
13. Watching movie, Chinese opera, hr times 1.3 
concert and drama 
14. Others (pis. Specify) hr times 
Sub-total : 




《 曰 常 活 動 問 卷 調 查 》 
姓名： 問卷編號： 
曰期： 年齡 ： 男 /女 










I 每 次 用 I 
多少小時 有多少次 
V I游泳 I “ 姆 I r 次 
現時你有否工作？ 有（請列明) 
否（如否請跳往第二頁作答） 






—1.坐著工作: 小時丨 ^ 
打字、收銀、案頭工作 















每次 平均一星^^^^^^ “^ 
用多少小 期 (埶g/l^鐘） 時 有多少次（@量7分鍾） 
乙部、一般活動 
1.購物（包括買菜、) 小時 次 ^ ： " 
—2.上/落班以外乘車時間 一 小 時 次 1.45 
—3.拿著重物上落樓梯 小 時 — 次 8 . 5 = 
—4.手洗、摺、赞、瞭乾衣物 _ 小 時 次 3.0 
一 5.簡單家務：收拾、掃地、 女 ,, 
_ 掉垃圾、淸潔 一 小 時 — — 坎 3 . 0 二 
6.需較大體能的家務：吸塵、 _ 为 ,, 
— 拖地、抹窗、搬像愀等 一 」 時 一 人 
7.預備飯餐(維持十分鐘以上)： ，丨賠 方 
一 切、洗食物、上菜、擺放食具一」守一人 
8.煮飯 一 小 時 次 2.7 
—9.餐後淸洗(維持十分鐘以上)： ，丨』去 方 , , " Z Z 
— 淸潔桌面、洗碗碟 ——」時——人 2.5 
10.簡單修理：修理小型電器、 爪沾 . ,, 
— 更換燈泡 一 術 — — ^ 3.0 z n 
11.需較大體能的修理： ，丨牲 卞 ,, 
— 修理像愀、洗車 一 小 時 一 次 5.5 二 
12三餐(合共)進食 一 小 時 一 次 1 . 3 8 —— 
S i f t — 小 時 次 —— 
乙部總和： 
丙部.照顧 
^1.照顧老人或殘障、行動不方便 7 1 r i “ 
—人仕：推輪椅、摻扶行走 一 」 、 時 一 次 
2.湊小孩子：抱、搖、背小孩、推 
車洗操、去遊樂場、接送上學 /放—小時—次 4.0 —— 
學 
3.照顧小動物 — 小 時 次 1.8 —— 
其他 — 小 時 一 次 = 




每次 平均一星\內碼 ~ 
用多少小 期 (熱量/分 
時 有多少次I鐘） 
丁部、運動（注意不包括運動前後更換衣服的時間X 
— 1 . 以較快速度步行 (維持十分鐘以 ^ 次I 60 Z Z 
—2.伸展手腳、瑜珈、太極、氣功 ，1 @ 一知 ^^ 
早操、柔軟體操 —小時 次 3 . 0 
- 3 . 較劇列運動如：健康舞、健身 _ _小時—次 6.0 —— 
—4.跳舞：社交舞、中國舞 — 小 時 — 次 5.5 
— 5 .保齡球 — 小 時 — 次 3.0 
— 6 .兵兵波 — 小 時 — 次 4.0 
—7.網球、羽毛球 — 小 時 — 次 7.0 
— 8 .哥爾夫球 _ _ 小 時 — 次 5.0 
—9.卓球、康樂棋 — 小 時 — 次 2.5 —— 
— 1 0 .踏單車 — 小 時 — 次 6.0 
— 1 1 .游泳 _ _ 小 時 — 次 6.0 
—12.排球 — 小 時 — 次 4.0 
—13.籃球 — 小 時 — 次 7.0 
— 1 4 .足球 — 小 時 — 次 8.0 
— 1 5 .壁球 一 小 時 — 次 11.4 
_ 1 6 .其他 ，丨胜 十 






用多少小 期 (熱量/分 
時 有多少次 鐘） 
戊部、悠閑活動： 
_ 1.散步（維持十分鐘以上） — 小 時 — 次 3.5 —— 
—2.縫紐、織冷衫、車衫 — 小 時 — 次 1.5 —— 
—3.釣魚 — 小 時 — 次 3.5 —— 
—4.彈奏樂器 小 時 — 次 2.9 —— 
—5.書法、給畫、書寫 — 小 時 — 次 1.7 —— 
—6.唱粵曲、唱卡拉0K _ _小時 次 2.4 
—7.下棋、打麻雀、玩撲克 (橋牌） _小時—次 1.5 —— 
_8.看電視、聽收音機 — 小 時 — 次 1.3 —— 
—9閱讀雜誌、報紙 — 小 時 — 次 1.3 —— 
—10.上網玩電腦 _ _ 小 時 — 次 1.6 —— 
—11.閑坐 — 小 時 — 次 1.3 
—12.宗教活動 小 時 — 次 1.3 —— 
— 1 3 .看電影、話劇、大戲、演唱會一小時—次 1.3 —— 
— 1 4 .其他 小 時 — 次 —— 
戊部總和： 
yVeight corrected Sum ： Kcal {daily) 
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Appendix 7 3-day Dietary Record 












12 /10 /99 ( 星 期 一 / 二 ( 三 1 四 / 五） 
^ 不用塡寫 
進 食 時 間 食 物 名 稱 進 食 份 量 
早 餐 “ 腿 蛋 治 T i 
(7:30 a . m . ) 維 他 奶 1 盒 250ml 
上 午 茶 梳 打 餅 T ^ 
(10:30a.m.) 中 國 茶 1 杯 
午餐 碎 牛 肉 粥 r ^ 
( 1 2 : 0 0 p . m . )油炸鬼 半 條 
鼓 油 王 米 粉 （ 炒 ） 1 小 碟 
下 午 茶 紅 提 子 
(3:30p.m.) 
晚 餐 1 中 碗 
(7:30 p . m . ) 白 菜 （ 炒 ） 1 碗 仔 
大魚（蒸） 少 許 
牛肉（炒） 5 片 
紅蘿蔔排骨湯（沒有進食湯渣） 1 碗 
睡 前 
( 8 : 3 0 p . m . )橙 1 個 




/ / (星期一 / 二 / 三 / 四 / 五 ） I 不 用 聽 
進 食 時 間 食 物 名 稱 進 食 份 量 
早餐 
( ) 













/ / (星期一 / 二 / 三 / 四 / 五 ） I 不 用 職 
進 食 時 間 食 物 名 稱 進 食 份 量 
早餐 
( ) 
上 午 茶 
( ) 
( ) 









/ / (星期一 / 二 / 三 / 四 / 五 ） | 不 _ 意 














Appendix 8 Olfactory Function Test 
嗅覺辮認測試 Olfactory Identificatiion Test (OIT) 















ist trial trial trial 
Picture Identification Multiple choice version of Olfactory Identification  
PIT  
1冬瑶 茶葉，墨汁，冬链 1.驅風油 
2驅風油 驅風油，牙膏，膠水 2.朱古力 
3杏仁 杏仁，花生’爽身粉 3.茶 
4 士多啤梨 膠水，士多啤梨，雞蛋 4.爽身粉 
5肥县 椰子，洗衣粉，肥县 5.花生 





































# 1. cm 
#2 cm 
# 3 cm 









Does the resident have beliefs that you know are not true? For example, saying that people are 
trying to harm him/her or steal from him/her. Has he/she said that family members are not who they 
say they are or that the house is not their home? I'm not asking about mere suspiciousness; I am 
interested if the patient is convinced that these things are happening to him/her. 
No (If no, proceed to next screening questionO. Yes (If yes, proceed to subquestions) 
1. does the patients believe that he/she is in danger - that others are planning to hurt him/her?  
2. Does the patient believe that others are stealing from him/her? 
3. Does patient believe that his/her spouse is having an affair?  
4. Does patient believe that unwelcome guests are living in his/her house?  
5. Does the patient believe that his/her spouse or others are not who they claim to be?  
6. Does the patient believe that his/her house is not his/her home?  
7. Does the patient believe that family members plan to abandon him/her?  
8. Does the patient believe that television or magazine figures are actually present in the home? 
[Does he/she try to talk or interact with them?]  
9. Does the he/she believe any other unusual things that I haven't asked about?  
If the screening question is confirmed, determine the frequency and severity of the delusions. 
Frequency: 1. Occasionally - less than once per week. 
2. Often — about once per week. 
3. Frequently - several times per week but less than every day. 
4. Very frequently — once or more per day. 
Severity: 1. Mild - delusions present but seem harmless and produce little distress in 
the patient. 
2. Moderate — delusions are distressing and disruptive. 
3. Marked - delusions are very disruptive and are a major source of 
behavioral disruption [If PRN medications are prescribed, their use signals 
that the delusions are of marked severity.] 
Distress: How emotionally distressing do you find this behavior? 









Does the patient have hallucinations such as false visions or voices? Does he/she seem to see, 
hear or experience things that are not present? By this question we do not mean just mistaken beliefs 
such as stating that someone who has died is still alive; rather we are asking if the patient actually has 
abnormal experiences of sounds, or visions. 
No (If no, proceed to next screening question). Yes (If yes, proceed to subquestions). 
Does the patient describe hearing voices or act if he/she hears voices?  
Does the patient talk to people who are not there?  
Does the patients describe seeming things not seen by others or behave as if he/she is seeing things 
not seen by others (people, animals, lights, etc.)?  
Does the patient report smelling odors not smelled by others?  
Does the patient describe feeling things on his/her skin or otherwise appear to be feeling things 
crawling or touching him/her?  
Does the patient describe tastes that are without any known cause?  
Does the patient describe any other unusual sensory experiences?  
If the screening question is confirmed, determine the frequency and severity of the hallucinations. 
Frequency: 1. Occasionally - less than once per week. 
2. Often - about once per week. 
3 Frequently - several times per week but less than every day. 
4. Very frequently — once or more per day. 
Severity: 1. Mild - hallucinations present but seem harmless and produce little distress 
in the patient. 
2. Moderate — hallucinations are distressing and disruptive. 
3. Marked - hallucinations are very disruptive and are a major source of 
behavioral disruption PRN medications may be required to control them 
Distress: How emotionally distressing do you find this behavior? 









Does the patient does have periods when he/she refuses to cooperate or won't let people help 
him/her? Is he/she hard to handle? 
No (If no, proceed to next screening question). Yes (If yes, proceed to subquestions). 
1. Does the patient get upset with those trying to care him/her or resist activities such as bathing or 
changing clothes?  
2. Is the patient stubborn, having to have things his/her way?  
3. Is the patient uncooperative, resistive to help from others?  
4. Does the patient have any other behaviors that make him hard to handle?  
5. Does the patient shout or curse angrily?  
6. Does the patient slam doors, kick furniture, and throw things?  
7. Does the patient attempt to hurt or hit others?  
8. Does the patient have any other aggressive or agitated behaviors?  
If the screening question is confirmed, determine the frequency and severity of the agitation. 
Frequency: 1. Occasionally - less than once per week. 
2. Cften - about once per week. 
3 Frequently - several times per week t at less than every day. 
4. Very frequently - once or more per day. 
Severity: 1. Mild — behavior is disruptive but can be managed with redirection or 
reassurance. 
2. Mt^derate - behaviors disruptive and diflicult to redirect or control. 
3. Marked - agitation is very disruptive and a major source of difficulty; there 
may be a threat of personal harm. Medications are often required. 
Distress: How emotionally distressing do you find this behavior? 









Does the patient seem sad or depressed? Does he/she say that he/she feels sad or depressed? 
No (If no, proceed to next screening questions). Yes (If yes, proceed to subquestions) 
1. Does the patient have period's tearfulness or sobbing that seem to indicate sadness?  
2. Does the patient say or act as if he/she is sad or in low spirits?  
3. Does the patient put him/herself down or say that he/she feels like a failure?  
4. Does the patient say that he/she is a bad person or deserves to be punished?  
5. Does the patient seem very discouraged or say that he/she has no future?  
6. Does the patient say he/she is a burden to the family or that the family would be better off without 
him/her?  
7. Does the patient express a wish for death or talk about killing him/herself?  
8. Does the patient show any other signs of depression or sadness?  
If the screening question is confirmed, determine the frequency and severity of the depression. 
Frequency: 1. Occasionally — less than once per week. 
2. Often - about once per week. 
3 Frequently - several times per week but less than every day. 
4. Very frequently — once or more per day. 
Severity: 1. Mild - depression is distressing but usually responds to redirection or 
reassurance 
2. Moderate - depression is distressing, depressive symptoms are 
spontaneously voiced by the patient and difficult to alleviate. 
3. Marked — depression is very distressing and a major source of suffering for 
the patient. 
Distress: How emotionally distressing do you find this behavior? 









Is the patient very nervous, worried, or frightened for no apparent reason? Does he/she seem 
very tense or fidgety? Is the patient afraid to be apart from you? 
No (If no, proceed to next screening question). Yes (If yes, proceed to subquestions). 
1. Does the patient say that he/she is worried about planned events?  
2. Does the patient have periods of feeling shaky, unable to relax, or feeling excessively tense? 
3. Does the patient have periods of [or complain of] shortness of breath, gasping, or sighing for no 
apparent reason other than nervousness?  
4. Does the patient complain of butterflies in his/her stomach, or of racing or pounding of the heart 
in association with nervousness? [Symptoms not explained by ill health]  
5. Does the patient avoid certain places or situations that make him/her more nervous such as riding 
in the car, meeting with friends, or being in crowds?  
6. Does the patient become nervous and upset when separated from you [or his/her caregiver]? 
[Does he/she cling to you to keep from being separated?]  
7. Does the patient show any other signs of anxiety?  
If the screening question is confirmed, determine the frequency and severity of the anxiety. 
Frequency: 1. Occasionally - less than once per week. 
2. Often - about once per week. 
3 Frequently - several times per week but less than every day. 
4. Very frequently - once or more per day. 
Severity: 1. Mild - anxiety is distressing but usually responds to redirection or 
reassurance 
2. Moderate 一 anxiety is distressing, depressive symptoms are spontaneously 
voiced by the patient and difficult to alleviate. 
3. Marked - anxiety is very distressing and a major source of suffering for the 
patient. 
Distress: How emotionally distressing do you find this behavior? 









Does the patient seem too cheerful or too happy for no reason? I don't mean the normal 
happiness that comes form seeing friends, receiving presents, or spending time with family members. 
I am asking if the patient has a persistent and abnormally good mood or finds humor where others do 
not. 
No (If no, proceed to next screening question). Yes (If yes, proceed to subquestions). 
1. Does the patient appear to feel too good or to be too happy, different from his/her usual self? 
2. Does the patient find humor and laugh at things that others do not find funny? 
3. Does the patient seem to have a childish sense of humor with a tendency to giggle or laugh 
inappropriately (such as when something unfortunate happens to others)?  
4. Does the patient tell jokes or make remarks that have little humor for others but seem funny to 
him/her?  
5. Does he/she play childish pranks such as pinching or playing "keep away" for the fun of it? 
6. Does the patient "talk big" or claim to have more abilities or wealth than is true?  
7. Does the patient show any other signs of feeling too good or being too happy?  
If the screening question is confirmed, determine the frequency and severity of the elation/euphoria. 
Frequency: 1. Occasionally - less than once per week. 
2. Often - about once per week. 
3 Frequently - several times per week but less than every day. 
4. Very frequently - once or more per day. 
Severity: 1. Mild — elation is notable to friends and family but is not disruptive 
2. Moderate - elation is notably abnormal. 
3. Marked - elation is very pronounced; patient is euphoric and finds nearly 
everything to be humorous. 
Distress: How emotionally distressing do you find this behavior? 









Has the patient lost interest in the world around him/her? Has he/she lost interest in doing 
things or lack motivation for starting new activities? Is he/she more difficult to engage in conversation 
or in doing chores? Is the patient apathetic or indifferent? 
No (If no, proceed to next screening question). Yes (If yes, proceed to subquestions). 
1. Does the patient seem less spontaneous and less active than usual?  
2. Is the patient less likely to initiate a conversation?  
3. Is the patient less affectionate or lacking in emotions when compared to his/her usual self?  
4. Does the patient contribute less to household chores? 
5. Does the patient seem less interested in the activities and plans of others?  
6. Has the patient lost interest in friends and family members?  
7. Is the patient less enthusiastic about his/her usual interests?  
8. Does the patient show any other signs that he/she doesn't care about doing new things?  
If the screening question is confirmed, determine the frequency and severity of the 
apathy/indifference. 
Frequency: 1. Occasionally - less than once per week. 
2. Often - about once per week. 
3 Frequently — several times per week but less than every day. 
4. Very frequently - once or more per day. 
Severity: 1. Mild - apathy is notable but produces little interference with daily routines; 
only mildly different from patient's usual behavior; patient responds to 
suggestions to engage in activities. 
2. Moderate - apathy is very evident; may be overcome by the caregiver with 
coaxing and encouragement; responds spontaneously only to powerful events 
such as visits from close relatives or family members. 
3. Marked -apathy is very evident and usually fails to respond to any 
encouragement or external events 
Distress: How emotionally distressing do you find this behavior? 









Does the patient seem to act impulsively without thinking? Does he/she do or say things that are 
not usually done or said in public? Does he/she do thing that are embarrassing to you or others? 
No (If no, proceed to the next screening question). Yes (If yes, proceed to subquestions). 
I. Does the patients act impulsively without appearing to consider the consequences?  
2. Does the patient talk to total strangers as if he/she knew them?  
3. Does the patient say things to people that are insensitive or hurt their feelings?  
4. Does the patient say crude things or make sexual remarks that they would not usually have said? 
5. Does the patient talk openly about very personal or private matters not usually discussed in public? 
6. Does the patient take liberties or touch or hug others in way that is out of character for hi,/her? 
7. Does the patient show any other signs of loss of control of his/her impulse?  
If the screening question is confirmed, determine the frequency and severity of the disinhibition. 
Frequency: 1. Occasionally - less than once per week. 
2. Ofter - about once per week. 
3 Frequently - several times per week but less than every day. 
4. Very frequently - once or more per day. 
Severity: 1. Mild - disinhibition is notable but usually responds to redirection and 
guidance 
2. Moderate - disinhibition is very evident and difficult to overome by the 
caregiver. 
3. Marked — disinhibition usually fails to respond to any intervention by the 
caregiver, and is a source of embarrassment or social distress. 
Distress: How emotionally distressing do you find this behavior? 









Does the patient get irritated and easily disturbed? Are his/her moods very changeable? Is he/she 
abnormally impatient? We do not mean frustration over memory loss or inability to perform usual 
tasks; we are interested to know if the patient has abnormal irritability, impatience, or rapid emotional 
changes different from his/her usual self. 
No (If no, proceed to next screening question). Yes (If yes, proceed to subquestions). 
1 • Does the patient have a bad temper, flying "off the handle" easily over little things?  
2. Does the patient rapidly change moods from one to another, being fine one minute and angry the 
next?  
3. Does the patient have sudden flashes of anger?  
4. Is the patient impatient; having trouble coping with delays or waiting for planned activities? 
5. Is the patient cranky and irritable?  
6. Is the patient argumentative and difficult to get along with?  
7. Does the patient show any other signs of irritability?  
If the screening question is confirmed, determine the frequency and severity of the irritability/lability. 
Frequency: 1. Occasionally - less than once per week. 
2. Often - about once per week. 
3 Frequently - several times per week but less than every day. 
4. Very frequently — once or more per day. 
Severity: 1. Mild - irritability or lability is notable but usually responds to redirection 
or reassurance 
2. Moderate - irritability and lability are very evident and difficult to 
overcome by the caregiver. 
3. Marked - irritability and lability are vsry evident, they usually fail to 
respond to any intervention by the caregiver, and they are a major source of 
distress. 
Distress: How emotionally distressing do you find this behavior? 





5. Very severely or extremely 
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Appendix 
J Aberrant Motor Behavior 
Does the patient pace, do things over and over such as opening closets or drawers, or repeatedly 
pick at things or wind string or threads? 
No (If no, proceed next screening question). Yes (If yes, proceed to subquestions). 
1. Does the patient pace around the house without apparent purpose?  
2. Does the patient rummage around opening and unpacking drawers or closets?  
3. Does the patients repeatedly put on and take off clothing?  
4. Does the patient have repetitive activities or "habits" that he/she performs over and over?  
5. Does the patient engage in repetitive activities such as handling buttons, picking, wrapping string, 
etc?  
6. Does the patient fidget excessively, seem unable to sit still, or bounce his/her feet or tap his/her 
fingers a lot?  
7. Does the patient do any other activities over and over? 
If the screening question is confirmed, determine the frequency and severity of the aberrant motor 
behavior. 
Frequency: 1. Occasionally - less than once per week. 
2. Often - about once per week. 
3 Frequently - several times per week but less than every day. 
4. Very frequently - once or more per day. 
Severity: 1. Mild - abnormal motor activity is notable but produce little interference 
with daily routines. 
2. Moderate -abnormal motor activity is very evident; can be overcome by 
the caregiver. 
3. Marked - abnormal motor activity is very evident, it usually fails to 
respond to any intervention by the caregiver and is a major source of distress. 
Distress: How emotionally distressing do you find this behavior? 









Does the patient have difficulty sleeping (do not count as present if the patient simply gets up 
once or twice per night only to go to the bathroom and falls back asleep immediately)? Is he/she up at 
night? Does he she wander at night, get dressed, or disturb your sleep? 
No (If no, proceed to next screening question). Yes (If yes, proceed to subquestions) 
1. Does the patient have difficulty falling asleep?  
2. Does the patient get up during the night (do not count if the patient gets up once or twice per 
night only to go to the bathroom and falls back asleep immediately)?  
3. Does the patient wander, pace, or get involved in inappropriate activities at night?  
4. Does the patient awaken you during the night?  
5. Does the patient awaken at night, dress, and plan to go out thinking that it is morning and time to 
start the day?  
6. Does the patient awaken too early in the morning 9earlier that was his/her habit)?  
7. Does the patient sleep excessively during the day?  
8. Does the patient have any other night-time behaviors that bother you that we haven't talked about? 
If the screening question is confirmed, determine the frequency and severity of the night-time 
behavior disturbances. 
Frequency: 1. Occasionally - less than once per week. 
2. Often — about once per week. 
3 Frequently - several times per week but less than every day. 
4. Very frequently - once or more per day. 
Severity: 1. Mild - night-time behaviors occur but they are not particularly disruptive. 
2. Moderate - night-time behaviors occur and disturb the patient and the 
sleep of caregiver; more than one type of night-time behavior may be present. 
3. Marked - night-time behaviors occur; several types of night-time behavior 
may be present; the patient is very distressed during the night and the 
caregiver's sleep is markedly disturbed. 
Distress: How emotionally distressing do you find this behavior? 





5. Very severely or extremely 
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Appendix 
L. Appetite and eating disorders 
Has he/she had any change in appetite, weight, or eating habits (count as NA if the patient is 
incapacitated and ahs to be fed)? Has there been any change in type of food he/she prefers? 
No (If no, this is the end of the questionnaire). Yes (If yes, proceed to subquestions). 
1. Has he/she had a loss of appetite?  
2. Has he/she had an increase in appetite?  
3. Has he/she had a loss of weight? 
4. Has he/she gained weight?  
5. Has he/she had a change in eating behavior such as putting too much food in his/her mouth at 
once?  
6. Has he/she had a change in the kind of food he/she likes such as eating too many sweets or other 
specific types of food?  
7. Has he/she developed eating behaviors such as eating exactly the same types of food each day or 
eating the food in exactly the same order? 
8. Have there been any other changes in appetite or eating that I haven't asked about?  
If the screening question is confirmed, determine the frequency and severity of the changes in eating 
habits or appetite. 
Frequency: 1. Occasionally — less than once per week. 
2. Often — about once per week. 
3 Frequently - several times per week but less than every day. 
4. Very frequently — once or more per day. 
Severity: 1. Mild - changes in appetite or eating are present but have not led to changes 
in weight and are not disturbing. 
2. Moderate - changes in appetite or eating are present and cause minor 
fluctuations in weight. 
3. Marked - obvious changes in appetite or eating are present and cause 
fluctuations in weight, are embarrassing, or otherwise disturb the patient. 
Distress: How emotionally distressing do you find this behavior? 





5. Very severely or extremely 
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頻 率 ： 1 . 偶 然 - - 一 週 少 於 一 次 
2. 經常 - -大約一週一次 
3. 頻繁…一週幾次但少於每天一次 
4 . 很 頻 繁 - - 每 天 一 次 或 更 多 
嚴重程度： 1. 輕度--妄想存在，但在病人身上並不造成傷害或困擾。 





























頻 率 ： 1 . 偶 然 - - 一 週 少 於 一 次 
2 . 經 常 - - 大 約 一 週 一 次 
3 .頻繁 - -一週幾次但少於每天一次 
4 . 很 頻 繁 - - 每 天 一 次 或 更 多 
嚴重程度： 1. 輕度--幻覺存在但在病人身上並不造成傷害或困擾。 

























頻 率 ： 1 . 偶 然 - - 一 週 少 於 一 次 
2 . 經 常 - - 大 約 一 週 一 次 
3. 頻繁 - -一週幾次但少於每天一次 
4. 很頻繁 - -每天一次或更多 
嚴重性： 1 .輕度 - -行爲具擾亂性或造成痳煩，能以指導或安撫的方法來處理 

























頻 率 ： 1 . 偶 然 - - 一 週 少 於 一 次 
2 . 經 常 - - 大 約 一 週 一 次 
3. 頻繁 - -一週幾次但少於每天一次 
4 . 很 頻 繁 - - 每 天 一 次 或 更 多 
嚴重程度： 1. 輕度--抑•造成困擾，但能以指導和安撫的方法來處理 
2 .中度 - -抑變造成困擾’抑變症狀由病人主動地用言語表達 
出來，且很難減輕 





3 . 中 度 





















頻 率 ： 1 . 偶 然 - - 一 週 少 於 一 次 
2 . 經 常 - - 大 約 一 週 一 次 
3 .頻繁 - -一週幾次但少於每天一次 
4. 很頻繁 - -每天一次或更多 
嚴重程度： 1. 輕度--焦慮造成困擾’但能以指導和安撫的方法來處理 




























頻率： 1. 偶然 - -一週少於一次 
2. 經常 - -大約一週一次 
3 .頻繁 - -一週幾次但少於每天一次 
4. 很頻繁 - -每天一次或更多 
嚴重程度： 1. 輕度--情緒高漲可被朋友或家人察覺到，但不具有破壞性。 
2 .中度…情緒高漲明顯地被覺察到是不正常。 
























頻 率 ： 1 . 偶 然 - - 一 週 少 於 一 次 
2. 經常 - -大約一週一次 
3. 頻繁 - -一週幾次但少於每天一次 
4 . 很 頻 繁 - - 每 天 一 次 或 更 多 










3 . 中 度 

















頻 率 ： 1 . 偶 然 - - 一 週 少 於 一 次 
2 . 經 常 - - 大 約 一 週 一 次 
3. 頻繁 - -一週幾次但少於每天一次 
4. 很頻繁 - -每天一次或更多 
嚴重性： 1 . 輕度--失去自制是明顯的，但常常對 t新指示或指導有反應。 
2. 中度--失去自制是非常明顯’且照顧者很難處理。 





2 . 輕 度 
3 . 中 度 

















頻 率 ： 1 . 偶 然 - - 一 週 少 於 一 次 
2. 經常 - -大約一週一次 
3. 頻繁 - -一週幾次但少於每天一次 
4 . 很 頻 繁 - - 每 天 一 次 或 更 多 
嚴重性： 1 . 輕度--易怒和情緒波動是明顯的但常常對重新指示或指導有反應。 







3 . 中 度 
















頻 率 ： 1 . 偶 然 - - 一 週 少 於 一 次 
2 . 經 常 - - 大 約 一 週 一 次 
3 .頻繁 - -一週幾次但少於每天一次 
4 . 很 頻 繁 - - 每 天 一 次 或 更 多 
嚴重程度： 1 .輕度 - -異常行爲被察覺，但不干擾日常生活。 
2 .中度 - -異常行爲很明顯，但照顧者能加以控制。 


























頻 率 ： 1 . 偶 然 - - — 週 少 於 一 次 
2 . 經 常 - - 大 約 一 週 一 次 
3. 頻繁 - -一週幾次但少於每天一次 
4. 很頻繁 - -每天一次或更多 
嚴重程度： 1 • 輕度--晚間行爲產生但並不引起特別的干擾。 
2 .中度 - -晚間行爲產生且干擾病人和照顧者的睡眠；有多于 
一種以上的夜間行爲存在 





2 . 輕 度 










2 .他 /她有食愁增加嗎？ 
3. 他/她有體重減輕嗎？ 









頻率： 1. 偶然 - -一週少於一次 
2 . 經 常 - - 大 約 一 週 一 次 
3 .頻繁 - -一週幾次但少於每天一次 
4. 很頻繁 - -每天一次或更多 
嚴重程度： 1.輕度--在食愁和進食方面有改變，但它並沒有弓丨起體重的改變， 
且無干擾。 
























 . . . . . I . . 
• 
. . .





















 - . s
 












































 ； ： ： 失 、
)
 : > : 「 ： ： 
. .
 ？



















 . … 一









C U H K l e s 
QD3fl7ES32 
